|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
severity |
ISO |
mRNA:decreased expression:liver (human) |
RGD |
PMID:16941710 PMID:30580964 |
RGD:1598532 RGD:24922199 |
NCBI chrNW_004955419:21,553,863...21,681,626
Ensembl chrNW_004955419:21,553,835...21,681,619
|
|
G |
Abcb1 |
ATP binding cassette subfamily B member 1 |
susceptibility |
ISO |
DNA:polymorphism: :c.3751G>A(human) CTD Direct Evidence: marker/mechanism DNA:polymorphism: : c.1465C > T(human) |
RGD CTD |
PMID:17510421 PMID:23488625 PMID:24175826 PMID:25625052 |
RGD:11041138 RGD:14700904 RGD:14700905 |
NCBI chrNW_004955432:4,911,774...5,085,349
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:25842354 |
RGD:11535155 |
NCBI chrNW_004955451:11,087,246...11,130,108
Ensembl chrNW_004955451:11,087,570...11,130,482
|
|
G |
Abce1 |
ATP binding cassette subfamily E member 1 |
|
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:21932399 |
RGD:11041873 |
NCBI chrNW_004955428:1,029,909...1,058,902
Ensembl chrNW_004955428:1,029,399...1,058,902
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
|
ISO |
|
RGD |
PMID:32171747 |
RGD:126907997 |
NCBI chrNW_004955513:652,048...799,182
Ensembl chrNW_004955513:653,252...799,239
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21147110 |
|
NCBI chrNW_004955451:679,033...909,892
Ensembl chrNW_004955451:600,254...909,892
|
|
G |
Acer3 |
alkaline ceramidase 3 |
disease_progression |
ISO |
|
RGD |
PMID:30097213 |
RGD:35673325 |
NCBI chrNW_004955414:14,741,027...14,846,931
Ensembl chrNW_004955414:14,746,529...14,848,151
|
|
G |
Acly |
ATP citrate lyase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21147110 |
|
NCBI chrNW_004955451:16,058,916...16,091,831
Ensembl chrNW_004955451:16,058,727...16,092,589
|
|
G |
Aco2 |
aconitase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955413:27,027,341...27,065,227
Ensembl chrNW_004955413:27,027,341...27,065,227
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12771043 PMID:15565109 |
|
NCBI chrNW_004955506:6,286,824...6,309,764
Ensembl chrNW_004955506:6,286,648...6,312,716
|
|
G |
Acsl4 |
acyl-CoA synthetase long chain family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 |
|
NCBI chrNW_004955490:6,143,833...6,228,395
Ensembl chrNW_004955490:6,143,833...6,228,452
|
|
G |
Actb |
actin beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 PMID:21472284 |
|
NCBI chrNW_004955460:10,358,100...10,361,585
Ensembl chrNW_004955460:10,356,699...10,361,585
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19514085 |
|
NCBI chrNW_004955407:26,524,487...26,533,038
Ensembl chrNW_004955407:26,524,130...26,533,038
|
|
G |
Adamts13 |
ADAM metallopeptidase with thrombospondin type 1 motif 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955513:2,761,386...2,786,447
Ensembl chrNW_004955513:2,764,186...2,786,187
|
|
G |
Add1 |
adducin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 |
|
NCBI chrNW_004955514:1,784,302...1,812,845
Ensembl chrNW_004955514:1,783,814...1,815,917
|
|
G |
Adgrg7 |
adhesion G protein-coupled receptor G7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955427:2,234,640...2,305,510
Ensembl chrNW_004955427:2,234,866...2,300,630
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
susceptibility |
ISO |
DNA:SNP:intron:+276T>G (rs1501299) (human) |
RGD |
PMID:23740135 |
RGD:14401720 |
NCBI chrNW_004955420:20,911,181...20,922,992
Ensembl chrNW_004955420:20,912,348...20,914,402
|
|
G |
Adra1a |
adrenoceptor alpha 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955403:49,394,173...49,485,881
Ensembl chrNW_004955403:49,399,127...49,485,934
|
|
G |
Adra2b |
adrenoceptor alpha 2B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955470:3,711,075...3,714,450
Ensembl chrNW_004955470:3,711,031...3,714,241
|
|
G |
Ak3 |
adenylate kinase 3 |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:17203974 |
RGD:13842477 |
NCBI chrNW_004955434:8,998,357...9,010,468
Ensembl chrNW_004955434:9,000,158...9,011,250
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32805337 |
|
NCBI chrNW_004955464:12,715,238...12,729,034
Ensembl chrNW_004955464:12,714,717...12,729,662
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
treatment exacerbates |
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver |
RGD CTD |
PMID:25999787 PMID:31801250 PMID:32045588 PMID:37460115 |
RGD:151893509 RGD:152177911 RGD:408364960 |
NCBI chrNW_004955538:3,208,711...3,224,386
Ensembl chrNW_004955538:3,208,710...3,229,904
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
|
ISO |
protein:increased phosphorylation:liver cancer cell (rat) protein:increased phosphorylation:liver (mouse) |
RGD |
PMID:19309364 PMID:28100771 |
RGD:127285675 RGD:2313299 |
NCBI chrNW_004955578:950,258...1,004,438
Ensembl chrNW_004955578:967,593...1,004,438
|
|
G |
Alb |
albumin |
susceptibility |
ISO |
associated with hepatitis C;protein:decreased expression:serum protein:decreased expression:serum (human) |
RGD |
PMID:22392353 PMID:23892757 PMID:29040987 |
RGD:11035269 RGD:125097525 RGD:14694841 |
NCBI chrNW_004955447:9,327...21,212
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
susceptibility no_association severity |
ISO |
protein:decreased expression: liver (human) DNA:missense mutation:exon 12: (human) associated with alcoholic liver cirrhosis;DNA:missense mutation:cds:p.E487K (human) associated with hepatitis B;DNA;missense mutation, haplotype:cds: (rs671) (human) mRNA, protein:decreased expression:liver (human) associated with alcohol use disorder;DNA:missense mutation:cds: (human) DNA:missense mutation:cds, exon 12:p.E487K (human) DNA:missense mutation:cds: (rs671) (human) associated with hepatitis C:DNA:SNP:exon 12 (human) |
RGD |
PMID:1916152 PMID:10737710 PMID:12940444 PMID:18439068 PMID:25778454 PMID:26150517 PMID:26827895 PMID:28027570 PMID:29765251 More...
|
RGD:11054822 RGD:14696699 RGD:14696778 RGD:14696779 RGD:14700899 RGD:15036809 RGD:15042857 RGD:15042859 RGD:15042862 |
NCBI chrNW_004955482:8,352,569...8,383,097
Ensembl chrNW_004955482:8,352,569...8,384,899
|
|
G |
Aldh7a1 |
aldehyde dehydrogenase 7 family member A1 |
severity |
ISO |
mRNA:altered expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004955521:4,365,075...4,396,105
Ensembl chrNW_004955521:4,364,638...4,396,129
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:3830170 |
RGD:2301136 |
NCBI chrNW_004955481:4,576,913...4,580,999
Ensembl chrNW_004955481:4,576,913...4,580,999
|
|
G |
Alx4 |
ALX homeobox 4 |
ameliorates |
ISO |
mRNA, protein:decreased expression:liver |
RGD |
PMID:28081728 PMID:31132711 |
RGD:153323329 RGD:153323330 |
NCBI chrNW_004955422:3,278,615...3,290,799
Ensembl chrNW_004955422:3,278,615...3,291,714
|
|
G |
Angptl6 |
angiopoietin like 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955495:1,437,024...1,446,328
Ensembl chrNW_004955495:1,437,239...1,441,236
|
|
G |
Ank3 |
ankyrin 3 |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:26652480 |
RGD:153344559 |
NCBI chrNW_004955425:13,522,233...13,851,286
|
|
G |
Anln |
anillin actin binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955460:6,972,077...7,033,900
Ensembl chrNW_004955460:6,947,508...7,033,669
|
|
G |
Antxr1 |
ANTXR cell adhesion molecule 1 |
treatment |
ISO |
|
RGD |
PMID:20650339 |
RGD:9684932 |
NCBI chrNW_004955424:15,820,734...16,034,278
Ensembl chrNW_004955424:15,824,435...16,033,946
|
|
G |
Anxa10 |
annexin A10 |
disease_progression |
ISO |
mRNA:decreased expression:liver (human) |
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004955403:37,780,428...37,821,212
Ensembl chrNW_004955403:37,780,044...37,845,808
|
|
G |
Anxa2 |
annexin A2 |
|
ISO |
mRNA, protein:increased expression:liver (human) |
RGD |
PMID:33675609 |
RGD:152999436 |
NCBI chrNW_004955450:14,545,586...14,574,161
Ensembl chrNW_004955450:14,512,381...14,574,696
|
|
G |
Anxa4 |
annexin A4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955424:15,323,604...15,389,136
Ensembl chrNW_004955424:15,321,990...15,389,136
|
|
G |
Anxa6 |
annexin A6 |
disease_progression |
ISO |
associated with tumor vascularization; protein:decreased expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004955408:2,522,027...2,565,862
Ensembl chrNW_004955408:2,522,027...2,570,426
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma |
OMIM ClinVar |
PMID:1316610 PMID:8381579 PMID:8381580 PMID:9536098 PMID:9585611 PMID:9824584 PMID:10713886 PMID:11001924 PMID:11247896 PMID:11317365 PMID:11466687 PMID:11748858 PMID:15311282 PMID:15459959 PMID:16461775 PMID:17293347 PMID:17411426 PMID:17489848 PMID:17576681 PMID:17963004 PMID:18199528 PMID:19531215 PMID:19793053 PMID:20223039 PMID:20685668 PMID:21859464 PMID:21901162 PMID:22135120 PMID:22425061 PMID:22431159 PMID:22447671 PMID:22703879 PMID:23159591 PMID:23460355 PMID:23484150 PMID:24033266 PMID:24448499 PMID:24573554 PMID:24599579 PMID:24728327 PMID:25186627 PMID:25479140 PMID:25559809 PMID:25590978 PMID:25637381 PMID:25741868 PMID:25925381 PMID:25980754 PMID:26207792 PMID:26447891 PMID:26467025 PMID:26530882 PMID:26580448 PMID:26690363 PMID:26845104 PMID:26900293 PMID:26976419 PMID:27028212 PMID:27081525 PMID:27150160 PMID:27600092 PMID:27852271 PMID:28051113 PMID:28127413 PMID:28135048 PMID:28135145 PMID:28195569 PMID:28492532 PMID:28526081 PMID:29641532 PMID:29684080 PMID:30267214 PMID:30374176 PMID:30458888 PMID:31428572 PMID:32390703 PMID:32658311 PMID:33294277 PMID:34426522 PMID:35189564 PMID:35264596 More...
|
|
NCBI chrNW_004955418:2,567,804...2,675,062
Ensembl chrNW_004955418:2,566,975...2,674,832
|
|
G |
Apcs |
amyloid P component, serum |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 |
|
NCBI chrNW_004955468:11,388,154...11,389,259
Ensembl chrNW_004955468:11,388,192...11,390,314
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25109342 PMID:33841550 |
RGD:152998960 |
NCBI chrNW_004955550:1,273,170...1,275,843
Ensembl chrNW_004955550:1,273,284...1,279,743
|
|
G |
Apln |
apelin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955473:5,346,822...5,356,359
Ensembl chrNW_004955473:5,346,747...5,356,359
|
|
G |
Apoa1 |
apolipoprotein A1 |
disease_progression |
ISO |
protein:decreased expression:plasma (human) associated with hepatitis B; CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:21472284 PMID:23935864 PMID:31211449 |
RGD:153350082 RGD:25671438 |
NCBI chrNW_004955412:18,170,331...18,172,298
Ensembl chrNW_004955412:18,170,331...18,172,298
|
|
G |
Apoa2 |
apolipoprotein A2 |
|
ISO |
associated with hepatitis B; mRNA:increased expression:liver |
RGD |
PMID:31211449 |
RGD:153350082 |
NCBI chrNW_004955468:12,977,956...12,979,282
Ensembl chrNW_004955468:12,977,956...12,979,753
|
|
G |
Apoa4 |
apolipoprotein A4 |
disease_progression |
ISO |
associated with hepatitis B; |
RGD |
PMID:31211449 |
RGD:153350082 |
NCBI chrNW_004955412:18,158,095...18,160,636
Ensembl chrNW_004955412:18,155,801...18,160,701
|
|
G |
Apoc1 |
apolipoprotein C1 |
disease_progression |
ISO |
associated with hepatitis B; |
RGD |
PMID:31211449 |
RGD:153350082 |
NCBI chrNW_004955555:2,005,962...2,007,239
|
|
G |
Apoc2 |
apolipoprotein C2 |
|
ISO |
associated with hepatitis B; mRNA:increased expression:liver |
RGD |
PMID:31211449 |
RGD:153350082 |
NCBI chrNW_004955555:2,019,547...2,021,543
Ensembl chrNW_004955555:2,016,217...2,021,830
|
|
G |
Apoc3 |
apolipoprotein C3 |
susceptibility disease_progression |
ISO |
associated with Chronic Hepatitis B;DNA:SNP: :rs2854116(human) associated with hepatitis B; |
RGD |
PMID:27547913 PMID:31211449 |
RGD:153344620 RGD:153350082 |
NCBI chrNW_004955412:18,165,667...18,168,015
Ensembl chrNW_004955412:18,165,667...18,168,015
|
|
G |
Apoc4 |
apolipoprotein C4 |
disease_progression |
ISO |
associated with hepatitis B; |
RGD |
PMID:31211449 |
RGD:153350082 |
NCBI chrNW_004955555:2,018,327...2,018,828
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
protein:increased expression:liver, serum (mouse) |
RGD |
PMID:21644509 |
RGD:6903288 |
NCBI chrNW_004955555:1,998,170...2,002,003
Ensembl chrNW_004955555:1,999,711...2,001,888
|
|
G |
Apof |
apolipoprotein F |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955458:3,973,734...3,978,312
|
|
G |
Aprt |
adenine phosphoribosyltransferase |
|
ISO |
protein:increased activity:hepatoma (rat) |
RGD |
PMID:6327016 |
RGD:5135035 |
NCBI chrNW_004955541:2,687,938...2,690,906
Ensembl chrNW_004955541:2,687,938...2,690,906
|
|
G |
Ar |
androgen receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18639551 |
|
NCBI chrNW_004955475:7,013,960...7,192,473
Ensembl chrNW_004955475:7,013,960...7,186,069
|
|
G |
Arg1 |
arginase 1 |
disease_progression |
ISO |
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) |
RGD |
PMID:17210712 PMID:30901224 |
RGD:152995286 RGD:4140476 |
NCBI chrNW_004955436:12,235,767...12,247,817
Ensembl chrNW_004955436:12,235,767...12,251,972
|
|
G |
Arhgap11a |
Rho GTPase activating protein 11A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955416:1,916,475...1,936,404
Ensembl chrNW_004955416:1,916,438...1,935,639
|
|
G |
Arhgap44 |
Rho GTPase activating protein 44 |
exacerbates |
ISO |
protein:decreased expression:liver (human) |
RGD |
PMID:31136984 |
RGD:401901276 |
NCBI chrNW_004955467:4,428,738...4,590,877
Ensembl chrNW_004955467:4,430,087...4,522,611
|
|
G |
Arhgef39 |
Rho guanine nucleotide exchange factor 39 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955472:633,474...636,440
Ensembl chrNW_004955472:633,405...640,305
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
treatment exacerbates |
ISO |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver (human) mRNA, protein:decreased expression:liver (human) human gene in mouse model associated with non-alcoholic steatohepatitis |
RGD CTD |
PMID:22561517 PMID:22634756 PMID:22922871 PMID:25975202 PMID:26569409 PMID:26589513 PMID:29113912 PMID:29136504 More...
|
RGD:11344640 RGD:125097485 RGD:125097495 RGD:125097519 RGD:126790634 |
NCBI chrNW_004955452:6,068,631...6,120,759
Ensembl chrNW_004955452:6,068,631...6,120,759
|
|
G |
Arid1b |
AT-rich interaction domain 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22634756 |
|
NCBI chrNW_004955439:5,041,111...5,454,692
Ensembl chrNW_004955439:5,043,967...5,412,741
|
|
G |
Arid2 |
AT-rich interaction domain 2 |
exacerbates disease_progression |
ISO |
associated with hepatitis B;protein:decreased expression:liver CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:21822264 PMID:22634756 PMID:25701229 PMID:27351279 PMID:28498550 PMID:32071245 More...
|
RGD:150340708 RGD:150340711 RGD:150340712 RGD:150429631 |
NCBI chrNW_004955500:4,998,555...5,177,180
Ensembl chrNW_004955500:4,998,555...5,175,776
|
|
G |
Arid3a |
AT-rich interaction domain 3A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35179300 |
|
NCBI chrNW_004955495:6,884,077...6,912,625
Ensembl chrNW_004955495:6,884,598...6,908,574
|
|
G |
Arrb2 |
arrestin beta 2 |
treatment |
ISO |
|
RGD |
PMID:33841550 |
RGD:152998960 |
NCBI chrNW_004955467:10,109,985...10,118,687
Ensembl chrNW_004955467:10,110,003...10,123,022
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955415:32,818,592...32,828,651
Ensembl chrNW_004955415:32,817,547...32,828,651
|
|
G |
Asl |
argininosuccinate lyase |
disease_progression |
ISO |
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004955456:8,409,767...8,419,915
Ensembl chrNW_004955456:8,411,220...8,416,992
|
|
G |
Aspg |
asparaginase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955538:2,765,215...2,785,390
Ensembl chrNW_004955538:2,765,104...2,785,526
|
|
G |
Aspm |
assembly factor for spindle microtubules |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:18676753 PMID:28284560 |
RGD:13439743 |
NCBI chrNW_004955406:33,665,675...33,720,468
Ensembl chrNW_004955406:33,661,322...33,720,259
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
disease_progression |
ISO |
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) |
RGD |
PMID:12359751 PMID:30901224 |
RGD:152995286 RGD:4140479 |
NCBI chrNW_004955513:443,372...485,190
Ensembl chrNW_004955513:445,462...485,190
|
|
G |
Atg101 |
autophagy related 101 |
disease_progression |
ISO |
|
RGD |
PMID:35592424 |
RGD:153350091 |
NCBI chrNW_004955547:2,436,974...2,446,849
Ensembl chrNW_004955547:2,436,895...2,446,849
|
|
G |
Atg7 |
autophagy related 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29191453 |
|
NCBI chrNW_004955429:14,076,976...14,301,034
Ensembl chrNW_004955429:14,076,960...14,304,236
|
|
G |
Atm |
ATM serine/threonine kinase |
exacerbates |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human) |
CTD RGD |
PMID:12866955 PMID:19919837 |
RGD:126781750 |
NCBI chrNW_004955412:10,422,753...10,531,406
Ensembl chrNW_004955412:10,426,135...10,530,545
|
|
G |
Atp5pb |
ATP synthase peripheral stalk-membrane subunit b |
|
ISO |
associated with hepatitis C |
RGD |
PMID:18932288 |
RGD:14696822 |
NCBI chrNW_004955435:14,940,502...14,952,423
Ensembl chrNW_004955435:14,940,434...14,954,310
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955553:1,893,767...1,897,175
Ensembl chrNW_004955553:1,892,670...1,897,175
|
|
G |
Aurka |
aurora kinase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955445:2,831,073...2,853,151
Ensembl chrNW_004955445:2,831,157...2,853,357
|
|
G |
Aurkb |
aurora kinase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955467:8,715,387...8,720,889
Ensembl chrNW_004955467:8,715,136...8,723,932
|
|
G |
Axin1 |
axin 1 |
disease_progression |
ISO |
ClinVar Annotator: match by term: AXIN1-related condition | ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma protein:decreased expression:liver (human) associated with Hepatitis B, Chronic,DNA:SNP, haplotype:exon:(rs1805105) T>C (human) |
OMIM ClinVar RGD |
PMID:10700176 PMID:25741868 PMID:26968103 PMID:28492532 PMID:31514071 PMID:37582359 More...
|
RGD:14402039 RGD:150530482 |
NCBI chrNW_004955442:16,845,728...16,898,301
Ensembl chrNW_004955442:16,843,152...16,898,430
|
|
G |
Axin2 |
axin 2 |
|
ISO |
protein:increased expression:liver: |
RGD |
PMID:11809809 |
RGD:151356508 |
NCBI chrNW_004955478:4,952,551...4,982,223
Ensembl chrNW_004955478:4,952,488...4,982,225
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
disease_progression |
ISO |
associated with hepatitis B;mRNA:decreased expression:liver |
RGD |
PMID:22625427 PMID:26902423 PMID:27993894 |
RGD:153350130 RGD:153350132 RGD:153350133 |
NCBI chrNW_004955573:902,153...910,481
Ensembl chrNW_004955573:899,798...912,272
|
|
G |
Azin1 |
antizyme inhibitor 1 |
disease_progression |
ISO |
RNA:increased editing:liver |
RGD |
PMID:23291631 |
RGD:14700705 |
NCBI chrNW_004955417:27,231,695...27,259,564
Ensembl chrNW_004955417:27,231,696...27,259,564
|
|
G |
Banf1 |
barrier to autointegration nuclear assembly factor 1 |
treatment |
ISO |
mRNA, protein:increased expression:liver (human) mRNA, protein:increased expression:liver (rat) |
RGD |
PMID:29059470 |
RGD:155791679 |
NCBI chrNW_004955422:19,337,038...19,338,824
Ensembl chrNW_004955422:19,337,038...19,338,824
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:33841550 |
RGD:152998960 |
NCBI chrNW_004955559:1,695,960...1,700,246
Ensembl chrNW_004955559:1,695,960...1,700,244
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment |
ISO |
mRNA:increased expression:liver (mouse) |
RGD |
PMID:28100771 PMID:33841550 |
RGD:127285675 RGD:152998960 |
NCBI chrNW_004955402:46,911,125...47,084,214
Ensembl chrNW_004955402:46,916,266...47,084,485
|
|
G |
Bcl2l1 |
BCL2 like 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:liver (mouse) |
CTD RGD |
PMID:10629087 PMID:11509945 PMID:28100771 PMID:33841550 |
RGD:127285675 RGD:152998960 |
NCBI chrNW_004955422:29,254,440...29,307,104
Ensembl chrNW_004955422:29,254,216...29,308,174
|
|
G |
Bco2 |
beta-carotene oxygenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955412:13,838,260...13,872,886
Ensembl chrNW_004955412:13,837,782...13,872,886
|
|
G |
Bcorl1 |
BCL6 corepressor like 1 |
disease_progression |
ISO |
|
RGD |
PMID:26879601 PMID:29679906 |
RGD:11556159 RGD:150340705 |
NCBI chrNW_004955473:4,990,974...5,054,829
Ensembl chrNW_004955473:4,989,366...5,054,925
|
|
G |
Bhmt |
betaine--homocysteine S-methyltransferase |
disease_progression |
ISO |
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004955425:21,992,219...22,009,389
Ensembl chrNW_004955425:21,991,665...22,009,855
|
|
G |
Bid |
BH3 interacting domain death agonist |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15289866 |
|
NCBI chrNW_004955454:5,776,656...5,785,500
Ensembl chrNW_004955454:5,777,667...5,783,118
|
|
G |
Birc3 |
baculoviral IAP repeat containing 3 |
exacerbates treatment ameliorates |
ISO |
associated with hepatitis B;mRNA, protein:increased expression:liver (human) human cell line in a mouse model |
RGD |
PMID:22682366 PMID:22820591 PMID:30210622 PMID:30368883 PMID:33310033 |
RGD:152998937 RGD:152998984 RGD:152998986 RGD:152998988 RGD:152999010 |
NCBI chrNW_004955412:5,624,865...5,643,520
Ensembl chrNW_004955412:5,628,973...5,643,410
|
|
G |
Birc7 |
baculoviral IAP repeat containing 7 |
exacerbates |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chrNW_004955528:919,246...922,581
Ensembl chrNW_004955528:919,246...922,619
|
|
G |
Blzf1 |
basic leucine zipper nuclear factor 1 |
disease_progression |
ISO |
|
RGD |
PMID:26342799 |
RGD:14398326 |
NCBI chrNW_004955462:7,856,650...7,879,659
Ensembl chrNW_004955462:7,855,075...7,879,186
|
|
G |
Bmi1 |
BMI1 proto-oncogene, polycomb ring finger |
treatment |
ISO |
|
RGD |
PMID:26919246 |
RGD:14928318 |
NCBI chrNW_004955429:6,548,586...6,553,730
Ensembl chrNW_004955429:6,547,731...6,558,105
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27222248 |
|
NCBI chrNW_004955494:2,567,238...2,712,708
|
|
G |
Bsg |
basigin (Ok blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36574092 |
|
NCBI chrNW_004955495:7,148,806...7,156,296
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18393292 |
|
NCBI chrNW_004955406:39,303,221...39,307,308
Ensembl chrNW_004955406:39,303,175...39,308,778
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955470:3,152,798...3,190,185
Ensembl chrNW_004955470:3,152,758...3,191,888
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955416:7,105,302...7,159,121
Ensembl chrNW_004955416:7,105,261...7,160,012
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:23245919 |
RGD:11040806 |
NCBI chrNW_004955495:2,796,601...2,824,233
Ensembl chrNW_004955495:2,796,663...2,824,697
|
|
G |
C9 |
complement C9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 PMID:28284560 |
|
NCBI chrNW_004955426:23,790,792...23,824,117
|
|
G |
Ca12 |
carbonic anhydrase 12 |
ameliorates disease_progression |
ISO |
mRNA:altered expression:liver |
RGD |
PMID:29900055 PMID:31934040 PMID:35362480 |
RGD:153352325 RGD:153352328 RGD:155226869 |
NCBI chrNW_004955450:11,927,730...11,975,553
Ensembl chrNW_004955450:11,943,340...11,975,928
|
|
G |
Ca2 |
carbonic anhydrase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955417:3,388,110...3,402,798
Ensembl chrNW_004955417:3,386,087...3,402,363
|
|
G |
Ca9 |
carbonic anhydrase 9 |
|
ISO |
mRNA:altered expression:liver |
RGD |
PMID:29900055 |
RGD:155226869 |
NCBI chrNW_004955472:619,084...625,570
Ensembl chrNW_004955472:619,245...625,051
|
|
G |
Cab39 |
calcium binding protein 39 |
disease_progression |
ISO |
|
RGD |
PMID:28605041 |
RGD:14398832 |
NCBI chrNW_004955453:4,582,530...4,670,978
Ensembl chrNW_004955453:4,582,530...4,671,157
|
|
G |
Cad |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
|
ISO |
DNA:amplification:cds (rat) mRNA:increased expression:liver |
RGD |
PMID:2888462 PMID:2914957 PMID:7053379 |
RGD:10755426 RGD:2303530 RGD:5132587 |
NCBI chrNW_004955469:9,203,433...9,227,526
Ensembl chrNW_004955469:9,203,434...9,227,865
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
|
ISO |
DNA, mRNA, protein:hypermethylation, decreased expression:promoter:liver |
RGD |
PMID:17428255 |
RGD:2289095 |
NCBI chrNW_004955412:16,673,401...17,005,082
Ensembl chrNW_004955412:16,669,099...17,005,014
|
|
G |
Cadm2 |
cell adhesion molecule 2 |
disease_progression |
ISO |
mRNA, protein:decreased expression:liver |
RGD |
PMID:24240726 |
RGD:15092075 |
NCBI chrNW_004955407:7,070,355...7,355,841
Ensembl chrNW_004955407:7,077,887...7,355,853
|
|
G |
Calr |
calreticulin |
exacerbates treatment |
ISO |
protein:increased expression:liver (human) human cells and recombinant gene in a mouse model |
RGD |
PMID:12096119 PMID:24997628 PMID:27055635 |
RGD:150521681 RGD:150521690 RGD:150521691 |
NCBI chrNW_004955415:31,985,147...31,989,372
Ensembl chrNW_004955415:31,985,147...31,989,372
|
|
G |
Camk2n1 |
calcium/calmodulin dependent protein kinase II inhibitor 1 |
|
ISO |
|
RGD |
PMID:23651211 |
RGD:18337283 |
NCBI chrNW_004955452:1,044,696...1,046,657
Ensembl chrNW_004955452:1,043,459...1,046,669
|
|
G |
Cap2 |
cyclase associated actin cytoskeleton regulatory protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955483:8,484,427...8,602,748
Ensembl chrNW_004955483:8,484,427...8,603,234
|
|
G |
Capn3 |
calpain 3 |
|
ISO |
mRNA:decreased expression:skeletal muscle |
RGD |
PMID:10806331 |
RGD:1600777 |
NCBI chrNW_004955416:9,070,479...9,121,099
Ensembl chrNW_004955416:9,070,399...9,117,794
|
|
G |
Carm1 |
coactivator associated arginine methyltransferase 1 |
|
ISO |
mRNA,protein:increased expression:liver: |
RGD |
PMID:23912631 |
RGD:9586718 |
NCBI chrNW_004955495:1,983,599...2,002,174
Ensembl chrNW_004955495:1,983,599...2,002,174
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:29133031 PMID:33841550 |
RGD:13782296 RGD:152998960 |
NCBI chrNW_004955403:24,315,712...24,326,271
|
|
G |
Casp8 |
caspase 8 |
treatment severity |
ISO |
associated with hepatitis B;DNA:insertion/deletion:promoter: (rs3834129) (human) |
OMIM RGD |
PMID:28643196 PMID:29133031 |
RGD:13782296 RGD:14695027 |
NCBI chrNW_004955403:322,082...348,591
Ensembl chrNW_004955403:322,555...347,053
|
|
G |
Casp9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:29133031 |
RGD:13782296 |
NCBI chrNW_004955527:2,613,691...2,630,217
Ensembl chrNW_004955527:2,613,683...2,629,738
|
|
G |
Cat |
catalase |
disease_progression |
ISO |
associated with liver cirrhosis with Hepatitis C;DNA:SNP:promoter:-262T>C (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:21907168 PMID:33010264 |
RGD:27095879 |
NCBI chrNW_004955422:11,783,973...11,826,970
Ensembl chrNW_004955422:11,781,835...11,827,464
|
|
G |
Cbfb |
core-binding factor subunit beta |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:17094378 |
RGD:126775147 |
NCBI chrNW_004955484:9,503,286...9,557,066
Ensembl chrNW_004955484:9,503,227...9,557,066
|
|
G |
Cbl |
Cbl proto-oncogene |
disease_progression |
ISO |
|
RGD |
PMID:26474280 |
RGD:11536137 |
NCBI chrNW_004955412:20,307,011...20,388,539
Ensembl chrNW_004955412:20,307,011...20,388,539
|
|
G |
Cbr1 |
carbonyl reductase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21056497 |
|
NCBI chrNW_004955407:35,351,601...35,354,510
|
|
G |
Cbx2 |
chromobox 2 |
disease_progression |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004955506:3,045,395...3,053,003
Ensembl chrNW_004955506:3,046,607...3,053,001
|
|
G |
Cbx4 |
chromobox 4 |
disease_progression |
ISO |
protein:increased expression:cytoplasm: |
RGD |
PMID:23943028 PMID:24838576 |
RGD:9586738 RGD:9586739 |
NCBI chrNW_004955506:2,998,241...3,002,788
Ensembl chrNW_004955506:2,998,237...3,002,788
|
|
G |
Cbx7 |
chromobox 7 |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:22041561 |
RGD:9587355 |
NCBI chrNW_004955413:25,079,627...25,100,039
Ensembl chrNW_004955413:25,086,186...25,100,039
|
|
G |
Ccbe1 |
collagen and calcium binding EGF domains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955402:43,551,810...43,819,731
Ensembl chrNW_004955402:43,555,924...43,819,706
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
|
ISO |
mRNA:increased expression:liver (mouse) |
RGD |
PMID:26569409 |
RGD:11344640 |
NCBI chrNW_004955481:9,085,943...9,089,147
|
|
G |
Ccl14 |
C-C motif chemokine ligand 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955481:10,336,758...10,340,397
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
treatment susceptibility |
ISO |
associated with alcoholic liver cirrhosis;DNA:SNP:promoter:-403G>A(human) DNA:polymorphisms:promoter:-403G>A,-28C>G (human) |
RGD |
PMID:21610221 PMID:22374185 PMID:28011329 |
RGD:14995306 RGD:14995333 RGD:14995338 |
NCBI chrNW_004955481:10,293,758...10,301,118
Ensembl chrNW_004955481:10,293,399...10,301,143
|
|
G |
Ccn1 |
cellular communication network factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17699798 |
|
NCBI chrNW_004955423:8,416,498...8,419,029
Ensembl chrNW_004955423:8,413,725...8,419,166
|
|
G |
Ccna1 |
cyclin A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12029619 |
|
NCBI chrNW_004955431:9,658,301...9,668,659
Ensembl chrNW_004955431:9,658,015...9,668,087
|
|
G |
Ccnb1 |
cyclin B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955446:140,661...149,500
Ensembl chrNW_004955446:140,093...149,500
|
|
G |
Ccnb2 |
cyclin B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955450:15,558,874...15,587,456
Ensembl chrNW_004955450:15,559,022...15,581,760
|
|
G |
Ccnd1 |
cyclin D1 |
susceptibility |
ISO |
associated with Hepatitis B, Chronic;DNA:SNP:splice-site mutation:870G>A (human) CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (mouse) |
RGD CTD |
PMID:12029619 PMID:19919837 PMID:22649188 PMID:25822088 PMID:25851350 PMID:26189965 PMID:28100771 More...
|
RGD:127285675 RGD:14401586 |
NCBI chrNW_004955422:16,449,921...16,462,676
Ensembl chrNW_004955422:16,448,770...16,463,300
|
|
G |
Ccnd2 |
cyclin D2 |
severity susceptibility disease_progression |
ISO |
associated with hepatitis B associated with Chronic Hepatitis C;DNA:SNP: :rs1049606(human) DNA:hypermethylation:CpG site |
RGD |
PMID:22004425 PMID:31059558 PMID:33320844 |
RGD:151664743 RGD:151665109 RGD:151665169 |
NCBI chrNW_004955413:2,083,351...2,108,450
Ensembl chrNW_004955413:2,083,351...2,103,430
|
|
G |
Ccne1 |
cyclin E1 |
ameliorates |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:12029619 PMID:17196522 PMID:22634754 PMID:28100771 PMID:29551768 |
RGD:127285675 RGD:153297807 RGD:2289277 |
NCBI chrNW_004955468:7,803,610...7,814,872
Ensembl chrNW_004955468:7,803,346...7,814,872
|
|
G |
Ccnf |
cyclin F |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955442:14,864,935...14,890,802
Ensembl chrNW_004955442:14,865,954...14,890,709
|
|
G |
Ccng1 |
cyclin G1 |
severity treatment disease_progression |
ISO |
protein:decreased expression:liver (human) human cells in mouse model protein:increased expression:liver (human) |
RGD |
PMID:19584283 PMID:22835824 PMID:23804702 PMID:24034575 PMID:25431954 PMID:26345095 PMID:27982046 PMID:33543294 More...
|
RGD:151356922 RGD:151356932 RGD:151356933 RGD:151356967 RGD:151356970 RGD:151356981 RGD:151361198 RGD:151361200 |
NCBI chrNW_004955408:16,846,050...16,850,365
|
|
G |
Ccng2 |
cyclin G2 |
|
ISO |
|
RGD |
PMID:27982046 |
RGD:151361200 |
NCBI chrNW_004955433:1,799,405...1,807,050
Ensembl chrNW_004955433:1,798,732...1,807,827
|
|
G |
Cd274 |
CD274 molecule |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism associated with hepatitis B associated with hepatitis B |
CTD RGD |
PMID:21912640 PMID:22396772 PMID:30267213 |
RGD:40818240 RGD:41410800 |
NCBI chrNW_004955434:9,487,309...9,508,366
Ensembl chrNW_004955434:9,487,315...9,505,904
|
|
G |
Cd276 |
CD276 molecule |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16217749 |
|
NCBI chrNW_004955450:3,884,437...3,896,416
|
|
G |
Cd34 |
CD34 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955406:43,116,688...43,130,405
Ensembl chrNW_004955406:43,117,816...43,130,463
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
|
RGD |
PMID:19016771 |
RGD:2313413 |
NCBI chrNW_004955489:8,465,571...8,477,714
Ensembl chrNW_004955489:8,465,164...8,477,746
|
|
G |
Cd5l |
CD5 molecule like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955468:9,670,958...9,690,331
Ensembl chrNW_004955468:9,667,514...9,689,150
|
|
G |
Cd68 |
CD68 molecule |
severity |
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:28656201 |
RGD:40924686 |
NCBI chrNW_004955467:9,340,490...9,343,912
Ensembl chrNW_004955467:9,341,364...9,343,836
|
|
G |
Cdc20 |
cell division cycle 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955537:2,941,265...2,945,158
Ensembl chrNW_004955537:2,941,265...2,945,158
|
|
G |
Cdc25c |
cell division cycle 25C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955418:2,114,053...2,138,513
|
|
G |
Cdc27 |
cell division cycle 27 |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma |
ClinVar |
|
|
NCBI chrNW_004955478:9,927,871...10,002,020
Ensembl chrNW_004955478:9,927,871...10,002,020
|
|
G |
Cdc45 |
cell division cycle 45 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955442:18,513,398...18,548,317
Ensembl chrNW_004955442:18,514,731...18,547,805
|
|
G |
Cdc6 |
cell division cycle 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955451:14,857,174...14,871,324
Ensembl chrNW_004955451:14,860,309...14,871,494
|
|
G |
Cdca2 |
cell division cycle associated 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955403:48,374,276...48,417,130
Ensembl chrNW_004955403:48,375,287...48,419,955
|
|
G |
Cdca3 |
cell division cycle associated 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955413:4,448,711...4,450,917
Ensembl chrNW_004955413:4,448,917...4,450,553
|
|
G |
Cdca5 |
cell division cycle associated 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955422:20,114,565...20,129,679
|
|
G |
Cdca8 |
cell division cycle associated 8 |
disease_progression |
ISO |
mRNA:increased expression:liver (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:28284560 PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004955452:15,486,515...15,501,838
Ensembl chrNW_004955452:15,486,452...15,499,867
|
|
G |
Cdh1 |
cadherin 1 |
severity |
ISO |
protein:decreased expression:liver DNA:hypermethylation mRNA:increased expression:liver |
RGD |
PMID:17295234 PMID:18837082 PMID:24840851 PMID:30697077 |
RGD:14402045 RGD:14402046 RGD:14402047 RGD:2289638 |
NCBI chrNW_004955484:7,782,409...7,861,082
Ensembl chrNW_004955484:7,782,772...7,860,967
|
|
G |
Cdh13 |
cadherin 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18425332 PMID:18553387 PMID:28284560 |
|
NCBI chrNW_004955564:407,120...1,549,880
Ensembl chrNW_004955564:408,730...1,426,841
|
|
G |
Cdk1 |
cyclin dependent kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human) |
CTD RGD |
PMID:19136513 PMID:28284560 |
RGD:2316317 |
NCBI chrNW_004955425:14,210,681...14,226,474
Ensembl chrNW_004955425:14,210,680...14,226,474
|
|
G |
Cdk12 |
cyclin dependent kinase 12 |
exacerbates |
ISO |
mRNA, protein:increased expression:liver (human) |
RGD |
PMID:31519701 |
RGD:151361172 |
NCBI chrNW_004955451:14,244,392...14,345,885
Ensembl chrNW_004955451:14,244,978...14,309,689
|
|
G |
Cdk13 |
cyclin dependent kinase 13 |
onset |
ISO |
DNA:amplification: : |
RGD |
PMID:22912832 |
RGD:155641228 |
NCBI chrNW_004955460:3,590,854...3,701,148
|
|
G |
Cdk14 |
cyclin dependent kinase 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22922871 |
|
NCBI chrNW_004955432:7,787,600...8,335,726
|
|
G |
Cdk4 |
cyclin dependent kinase 4 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:26189965 PMID:33841550 |
RGD:152998960 |
NCBI chrNW_004955458:5,457,927...5,460,718
Ensembl chrNW_004955458:5,453,732...5,460,718
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
|
ISO |
OMIM:114550 |
MouseDO |
|
|
NCBI chrNW_004955437:6,254,638...6,261,278
Ensembl chrNW_004955437:6,254,309...6,261,479
|
|
G |
Cdkn1b |
cyclin dependent kinase inhibitor 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20698225 |
|
NCBI chrNW_004955413:9,615,542...9,620,542
Ensembl chrNW_004955413:9,615,542...9,620,542
|
|
G |
Cdkn1c |
cyclin dependent kinase inhibitor 1C |
severity |
ISO |
protein:decreased expression:liver (human) |
RGD |
PMID:26606000 |
RGD:11354707 |
NCBI chrNW_004955422:14,576,971...14,578,868
|
|
G |
Cdkn2b |
cyclin dependent kinase inhibitor 2B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33010264 |
|
NCBI chrNW_004955472:12,275,613...12,280,141
Ensembl chrNW_004955472:12,275,544...12,280,528
|
|
G |
Cdkn2c |
cyclin dependent kinase inhibitor 2C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955464:8,022,596...8,028,241
Ensembl chrNW_004955464:8,021,887...8,028,241
|
|
G |
Cdkn3 |
cyclin dependent kinase inhibitor 3 |
severity treatment |
ISO |
mRNA:increased expression:liver associated with alcoholism; protein:increased expression:liver protein:decreased expression:liver CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:22390936 PMID:23292002 PMID:27314282 PMID:28284560 |
RGD:15090800 RGD:15090801 RGD:15090802 |
NCBI chrNW_004955409:9,015,220...9,030,983
Ensembl chrNW_004955409:9,015,353...9,031,050
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955541:2,683,030...2,687,883
Ensembl chrNW_004955541:2,683,408...2,687,102
|
|
G |
Cebpa |
CCAAT enhancer binding protein alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16288022 PMID:21785164 |
|
NCBI chrNW_004955468:3,046,544...3,049,217
Ensembl chrNW_004955468:3,047,931...3,049,080
|
|
G |
Cebpb |
CCAAT enhancer binding protein beta |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (human) |
CTD RGD |
PMID:14563831 PMID:30659195 |
RGD:40903042 |
NCBI chrNW_004955445:8,060,432...8,061,289
|
|
G |
Cebpd |
CCAAT enhancer binding protein delta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14563831 |
|
NCBI chrNW_004955454:7,711,010...7,711,680
|
|
G |
Celsr3 |
cadherin EGF LAG seven-pass G-type receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955532:724,306...749,192
Ensembl chrNW_004955532:725,243...749,173
|
|
G |
Cenpa |
centromere protein A |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human) |
CTD RGD |
PMID:21956590 PMID:28284560 |
RGD:36947377 |
NCBI chrNW_004955469:8,799,312...8,819,637
Ensembl chrNW_004955469:8,799,071...8,819,876
|
|
G |
Cenpe |
centromere protein E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955496:5,468,759...5,514,915
Ensembl chrNW_004955496:5,469,239...5,513,574
|
|
G |
Cenpf |
centromere protein F |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955406:3,225,788...3,273,037
Ensembl chrNW_004955406:3,223,993...3,273,714
|
|
G |
Cenpm |
centromere protein M |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955413:27,349,283...27,360,052
Ensembl chrNW_004955413:27,349,283...27,360,052
|
|
G |
Cenpu |
centromere protein U |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955403:24,245,197...24,278,631
Ensembl chrNW_004955403:24,245,185...24,279,734
|
|
G |
Cenpw |
centromere protein W |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955436:7,557,595...7,563,238
Ensembl chrNW_004955436:7,557,251...7,566,443
|
|
G |
Cep131 |
centrosomal protein 131 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955506:1,783,717...1,809,665
Ensembl chrNW_004955506:1,783,689...1,809,653
|
|
G |
Cep164 |
centrosomal protein 164 |
susceptibility |
ISO |
associated with Chronic Hepatitis C;DNA:SNP: :rs573455 (human) |
RGD |
PMID:22004425 |
RGD:151665169 |
NCBI chrNW_004955412:18,627,023...18,695,685
Ensembl chrNW_004955412:18,634,074...18,694,346
|
|
G |
Cep55 |
centrosomal protein 55 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955507:2,384...25,105
Ensembl chrNW_004955507:2,296...26,911
|
|
G |
Cfp |
complement factor properdin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955516:449,993...455,897
Ensembl chrNW_004955516:449,993...456,492
|
|
G |
Chaf1b |
chromatin assembly factor 1 subunit B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955407:35,601,992...35,618,287
Ensembl chrNW_004955407:35,602,819...35,617,917
|
|
G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
exacerbates |
ISO |
mRNA:increased expression:liver (human) protein:increased expression:liver (human) |
RGD |
PMID:26095183 PMID:28486105 PMID:32070428 |
RGD:11571740 RGD:153323299 RGD:153323308 |
NCBI chrNW_004955413:4,191,619...4,228,225
Ensembl chrNW_004955413:4,191,619...4,228,225
|
|
G |
Chd5 |
chromodomain helicase DNA binding protein 5 |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:26517514 |
RGD:11537550 |
NCBI chrNW_004955486:6,320,380...6,369,020
Ensembl chrNW_004955486:6,320,380...6,369,065
|
|
G |
Ckap2l |
cytoskeleton associated protein 2 like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955470:1,552,279...1,581,261
Ensembl chrNW_004955470:1,552,128...1,581,980
|
|
G |
Ckap4 |
cytoskeleton associated protein 4 |
disease_progression |
ISO |
associated with tumor vascularization; mRNA,protein:increased expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004955405:40,277,082...40,279,486
|
|
G |
Cldn1 |
claudin 1 |
severity |
ISO |
associated with liver cirrhosis;protein:increased expression:liver (human) protein:decreased expression:liver (human) |
RGD |
PMID:17270214 PMID:24696415 PMID:24815833 |
RGD:26884345 RGD:26884348 RGD:26884352 |
NCBI chrNW_004955420:17,798,974...17,815,049
Ensembl chrNW_004955420:17,798,974...17,815,205
|
|
G |
Clec1b |
C-type lectin domain family 1 member B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955413:7,812,750...7,821,620
Ensembl chrNW_004955413:7,812,552...7,819,060
|
|
G |
Clec4g |
C-type lectin domain family 4 member G |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955563:1,571,374...1,574,901
Ensembl chrNW_004955563:1,571,288...1,575,979
|
|
G |
Clptm1l |
CLPTM1 like |
susceptibility disease_progression |
ISO |
DNA:SNPs::rs401681(human) DNA:SNP: :rs401681(human) |
RGD |
PMID:25339005 PMID:29042796 |
RGD:150530496 RGD:150537100 |
NCBI chrNW_004955504:677,824...695,660
Ensembl chrNW_004955504:677,772...695,660
|
|
G |
Cltrn |
collectrin, amino acid transport regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955519:2,522,154...2,569,722
Ensembl chrNW_004955519:2,522,155...2,570,972
|
|
G |
Cndp1 |
carnosine dipeptidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955402:57,970,205...58,019,980
Ensembl chrNW_004955402:57,970,161...58,019,479
|
|
G |
Cntnap4 |
contactin associated protein family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955484:258,232...521,133
Ensembl chrNW_004955484:256,328...521,073
|
|
G |
Col15a1 |
collagen type XV alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955419:26,577,172...26,687,750
Ensembl chrNW_004955419:26,574,835...26,687,803
|
|
G |
Col18a1 |
collagen type XVIII alpha 1 chain |
severity |
ISO |
Protein:increased expression |
RGD |
PMID:15739185 |
RGD:1600906 |
NCBI chrNW_004955407:42,091,211...42,131,343
Ensembl chrNW_004955407:42,091,211...42,131,343
|
|
G |
Colec10 |
collectin subfamily member 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955417:24,954,969...24,994,188
Ensembl chrNW_004955417:24,954,938...24,994,188
|
|
G |
Comt |
catechol-O-methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15341023 |
|
NCBI chrNW_004955442:18,130,282...18,152,153
Ensembl chrNW_004955442:18,130,987...18,137,412
|
|
G |
Cops5 |
COP9 signalosome subunit 5 |
severity |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human) |
CTD RGD |
PMID:20698225 PMID:26606000 |
RGD:11354707 |
NCBI chrNW_004955444:12,217,337...12,233,570
Ensembl chrNW_004955444:12,217,337...12,234,193
|
|
G |
Cp |
ceruloplasmin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19229483 |
|
NCBI chrNW_004955448:470,063...522,909
Ensembl chrNW_004955448:473,179...523,100
|
|
G |
Cpeb3 |
cytoplasmic polyadenylation element binding protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955425:1,032,446...1,224,300
Ensembl chrNW_004955425:1,057,575...1,224,300
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
disease_progression |
ISO |
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004955457:4,848,116...4,961,384
Ensembl chrNW_004955457:4,844,152...4,961,246
|
|
G |
Crebbp |
CREB binding protein |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: LIVER CELL CARCINOMA |
ClinVar |
PMID:21390126 PMID:21680795 PMID:21796119 PMID:22832583 PMID:23334668 PMID:23685749 PMID:23778141 PMID:25741868 PMID:26087898 PMID:26619011 PMID:27257180 PMID:28492532 PMID:28970362 PMID:29551561 PMID:33560380 More...
|
|
NCBI chrNW_004955442:13,559,496...13,691,913
Ensembl chrNW_004955442:13,559,496...13,692,004
|
|
G |
Crhbp |
corticotropin releasing hormone binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955425:23,953,957...23,966,207
Ensembl chrNW_004955425:23,953,912...23,966,352
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
exacerbates severity |
ISO |
mRNA:increased expression:liver (human) protein:increased expression: liver (human) DNA:hypomethylation DNA:hypomethylation:promoter (human) protein:increased expression:liver (human) |
RGD |
PMID:11412385 PMID:14969845 PMID:20551429 PMID:32724427 PMID:32760707 |
RGD:150524279 RGD:150524282 RGD:150524286 RGD:150524301 RGD:150524302 |
NCBI chrNW_004955415:4,434,486...4,462,505
Ensembl chrNW_004955415:4,434,453...4,461,751
|
|
G |
Csf2 |
colony stimulating factor 2 |
treatment |
ISO |
|
RGD |
PMID:12731087 |
RGD:10450243 |
NCBI chrNW_004955408:3,452,009...3,454,255
Ensembl chrNW_004955408:3,451,965...3,454,312
|
|
G |
Csk |
C-terminal Src kinase |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:9918913 |
RGD:5134372 |
NCBI chrNW_004955450:3,127,561...3,144,550
Ensembl chrNW_004955450:3,127,561...3,144,550
|
|
G |
Csmd1 |
CUB and Sushi multiple domains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955403:55,809,895...57,101,986
Ensembl chrNW_004955403:55,851,519...57,099,067
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955450:2,631,310...2,663,118
Ensembl chrNW_004955450:2,631,327...2,662,269
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955427:24,825,010...24,830,030
Ensembl chrNW_004955427:24,825,010...24,828,988
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
susceptibility |
ISO |
DNA:SNPs: :rs231775,rs231725(human) protein:increased expression:CD4+ and CD8+ T cells: |
RGD |
PMID:23432218 PMID:28648905 |
RGD:14398741 RGD:14398742 |
NCBI chrNW_004955457:11,028,707...11,034,898
Ensembl chrNW_004955457:11,028,698...11,073,460
|
|
G |
Ctnnb1 |
catenin beta 1 |
exacerbates susceptibility severity |
ISO |
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar Annotator: match by term: AXIN1-related condition | ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma | ClinVar Annotator: match by term: LIVER CELL CARCINOMA DNA:missense mutations:exon 3:multiple (human) associated with Hepatitis B, Chronic,DNA:SNP, haplotype: :rs3864004 (human) DNA:Mutations:exon: associated with hepatitis B;DNA:SNPs: :rs3864004,rs11564475(human) |
OMIM ClinVar RGD |
PMID:9065402 PMID:9065403 PMID:9294210 PMID:9500465 PMID:9927029 PMID:10027390 PMID:10192393 PMID:10391090 PMID:10398436 PMID:10435629 PMID:10655994 PMID:10666372 PMID:11351304 PMID:11930117 PMID:11950921 PMID:12124804 PMID:15133491 PMID:19101982 PMID:19234609 PMID:21903672 PMID:23033978 PMID:23265383 PMID:24614104 PMID:24728327 PMID:24788118 PMID:25157968 PMID:25326635 PMID:25326669 PMID:25741868 PMID:26350204 PMID:26502894 PMID:26619011 PMID:26822237 PMID:26968103 PMID:27276713 PMID:27915094 PMID:27959697 PMID:28328801 PMID:28333917 PMID:28492532 PMID:28575650 PMID:29682453 PMID:30640974 PMID:31526516 More...
|
RGD:14402039 RGD:14402040 RGD:14402052 RGD:150429592 |
NCBI chrNW_004955420:29,030,716...29,047,447
Ensembl chrNW_004955420:29,030,716...29,047,449
|
|
G |
Ctsb |
cathepsin B |
|
ISO |
|
RGD |
PMID:15641152 |
RGD:2315605 |
NCBI chrNW_004955403:53,086,236...53,100,217
Ensembl chrNW_004955403:53,085,574...53,093,809
|
|
G |
Ctsd |
cathepsin D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955422:13,576,315...13,584,267
Ensembl chrNW_004955422:13,576,202...13,584,298
|
|
G |
Cux1 |
cut like homeobox 1 |
|
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:30561038 |
RGD:152985541 |
NCBI chrNW_004955456:15,292,562...15,636,835
Ensembl chrNW_004955456:15,276,959...15,638,004
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
treatment disease_progression |
ISO |
|
RGD |
PMID:27245433 PMID:28592115 PMID:28638480 |
RGD:27095889 RGD:27095898 RGD:27095899 |
NCBI chrNW_004955433:748,392...750,890
Ensembl chrNW_004955433:748,284...750,927
|
|
G |
Cxcl11 |
C-X-C motif chemokine ligand 11 |
|
ISO |
mRNA:increased expression:liver (mouse) |
RGD |
PMID:26569409 |
RGD:11344640 |
NCBI chrNW_004955433:769,449...771,137
Ensembl chrNW_004955433:766,272...771,231
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 PMID:28284560 |
|
NCBI chrNW_004955546:1,929,269...1,941,690
Ensembl chrNW_004955546:1,929,269...1,941,690
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955408:30,733,079...30,740,854
Ensembl chrNW_004955408:30,733,079...30,740,854
|
|
G |
Cxcl8 |
C-X-C motif chemokine ligand 8 |
susceptibility disease_progression |
ISO |
mRNA:increased expression:liver (human) CTD Direct Evidence: marker/mechanism|therapeutic DNA:SNPs, haplotype:multiple protein:increased expression:liver (human) |
RGD CTD |
PMID:12432545 PMID:24381110 PMID:26078356 PMID:30523154 PMID:35776891 |
RGD:11526468 RGD:26884364 RGD:26884366 |
NCBI chrNW_004955474:247,326...250,355
Ensembl chrNW_004955474:241,501...250,643
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
severity treatment |
ISO |
protein:increased expression:liver (human) human cells in mouse model |
RGD |
PMID:30034941 PMID:33574707 |
RGD:151665327 RGD:151665331 |
NCBI chrNW_004955440:3,456,165...3,460,024
Ensembl chrNW_004955440:3,455,153...3,460,109
|
|
G |
Cyld |
CYLD lysine 63 deubiquitinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21109933 |
|
NCBI chrNW_004955433:8,788,867...8,845,925
Ensembl chrNW_004955433:8,788,655...8,845,925
|
|
G |
Dab2ip |
DAB2 interacting protein |
severity |
ISO |
protein:decreased expression:liver (human) mRNA:decreased expression:liver (human) |
RGD |
PMID:22168621 PMID:31176165 |
RGD:151665110 RGD:151665148 |
NCBI chrNW_004955419:6,229,437...6,416,619
Ensembl chrNW_004955419:6,228,591...6,416,402
|
|
G |
Dbh |
dopamine beta-hydroxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955513:2,918,085...2,932,481
Ensembl chrNW_004955513:2,918,286...2,932,247
|
|
G |
Dcn |
decorin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955405:28,335,493...28,371,912
Ensembl chrNW_004955405:28,332,545...28,372,323
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
severity |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:33173221 |
RGD:151347691 |
NCBI chrNW_004955583:820,893...838,515
Ensembl chrNW_004955583:820,931...841,654
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
treatment disease_progression |
ISO |
|
RGD |
PMID:26362312 PMID:33969575 |
RGD:11086753 RGD:150429748 |
NCBI chrNW_004955462:13,578,638...13,644,834
Ensembl chrNW_004955462:13,584,724...13,642,968
|
|
G |
Ddx3x |
DEAD-box helicase 3 X-linked |
exacerbates sexual_dimorphism |
ISO |
associated with hepatitis B; mRNA,protein:decreased expression:liver (human) |
RGD |
PMID:16301996 PMID:30297359 |
RGD:151356499 RGD:151356660 |
NCBI chrNW_004955565:1,387,043...1,403,624
Ensembl chrNW_004955565:1,386,973...1,404,220
|
|
G |
Depdc1 |
DEP domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955423:23,137,841...23,157,548
Ensembl chrNW_004955423:23,137,835...23,159,385
|
|
G |
Depdc1b |
DEP domain containing 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955446:7,792,778...7,857,218
Ensembl chrNW_004955446:7,792,756...7,858,615
|
|
G |
Depdc5 |
DEP domain containing 5, GATOR1 subcomplex subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21725309 |
|
NCBI chrNW_004955455:5,881,631...6,005,514
Ensembl chrNW_004955455:5,881,691...6,003,035
|
|
G |
Dhfr |
dihydrofolate reductase |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular cancer |
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004955418:29,274,170...29,283,028
|
|
G |
Dicer1 |
dicer 1, ribonuclease III |
susceptibility |
ISO |
associated with hepatitis B; DNA:SNP: :rs1057035 T>C (human) |
RGD |
PMID:23868705 |
RGD:149735346 |
NCBI chrNW_004955438:17,374,899...17,431,599
Ensembl chrNW_004955438:17,382,493...17,431,797
|
|
G |
Dipk2b |
divergent protein kinase domain 2B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955516:3,041,112...3,081,740
Ensembl chrNW_004955516:3,041,092...3,083,491
|
|
G |
Dlgap5 |
DLG associated protein 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955409:8,408,040...8,445,587
Ensembl chrNW_004955409:8,408,453...8,445,876
|
|
G |
Dlk1 |
delta like non-canonical Notch ligand 1 |
|
ISO |
mRNA:increased expression:liver (mouse) |
RGD |
PMID:26569409 |
RGD:11344640 |
NCBI chrNW_004955627:37,886...43,730
Ensembl chrNW_004955627:38,128...43,728
|
|
G |
Dmgdh |
dimethylglycine dehydrogenase |
disease_progression |
ISO |
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004955425:22,045,977...22,103,381
Ensembl chrNW_004955425:22,045,993...22,102,852
|
|
G |
Dnajc6 |
DnaJ heat shock protein family (Hsp40) member C6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955423:25,269,459...25,382,664
Ensembl chrNW_004955423:25,269,466...25,377,641
|
|
G |
Dnase1l3 |
deoxyribonuclease 1L3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955430:7,867,172...7,892,079
Ensembl chrNW_004955430:7,867,109...7,892,079
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:11844796 |
RGD:2289670 |
NCBI chrNW_004955495:1,465,529...1,505,379
Ensembl chrNW_004955495:1,465,480...1,505,462
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
|
ISO |
mRNA, protein:increased expression:liver protein:increased expression:liver: |
RGD |
PMID:11844796 PMID:15885882 |
RGD:2289670 RGD:9588598 |
NCBI chrNW_004955469:7,264,431...7,367,059
Ensembl chrNW_004955469:7,269,952...7,367,059
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
|
ISO |
mRNA, protein:increased expression:liver mRNA:increased expression:liver: |
RGD |
PMID:11844796 PMID:15885882 |
RGD:2289670 RGD:9588598 |
NCBI chrNW_004955422:28,380,595...28,427,012
Ensembl chrNW_004955422:28,380,591...28,421,301
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18019677 |
|
NCBI chrNW_004955435:2,007,185...2,800,907
Ensembl chrNW_004955435:2,007,185...2,766,138
|
|
G |
Dsn1 |
DSN1 component of MIS12 kinetochore complex |
disease_progression |
ISO |
|
RGD |
PMID:30136646 |
RGD:27372884 |
NCBI chrNW_004955422:24,876,340...24,896,435
|
|
G |
Dtl |
denticleless E3 ubiquitin protein ligase homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955406:5,256,057...5,299,573
Ensembl chrNW_004955406:5,254,558...5,299,573
|
|
G |
Dynlrb1 |
dynein light chain roadblock-type 1 |
|
ISO |
|
RGD |
PMID:11750132 |
RGD:13208527 |
NCBI chrNW_004955422:26,787,879...26,807,901
Ensembl chrNW_004955422:26,787,699...26,807,901
|
|
G |
Dynlrb2 |
dynein light chain roadblock-type 2 |
|
ISO |
|
RGD |
PMID:11750132 |
RGD:13208527 |
NCBI chrNW_004955522:3,353,087...3,364,276
Ensembl chrNW_004955522:3,353,087...3,365,045
|
|
G |
E2f1 |
E2F transcription factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12029619 PMID:15565109 PMID:28284560 |
|
NCBI chrNW_004955422:27,638,625...27,643,261
Ensembl chrNW_004955422:27,633,827...27,642,241
|
|
G |
E2f8 |
E2F transcription factor 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955476:197,699...215,227
Ensembl chrNW_004955476:197,630...213,441
|
|
G |
Eaf2 |
ELL associated factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20564326 |
|
NCBI chrNW_004955427:21,171,900...21,204,138
Ensembl chrNW_004955427:21,172,009...21,204,051
|
|
G |
Ecm1 |
extracellular matrix protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955413:293,295...299,293
Ensembl chrNW_004955413:290,363...299,130
|
|
G |
Ect2 |
epithelial cell transforming 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955420:2,769,542...2,827,843
Ensembl chrNW_004955420:2,768,800...2,828,230
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
exacerbates |
ISO |
protein:increased expression, increased phosphorylation:liver (human) |
RGD |
PMID:28060762 |
RGD:153298915 |
NCBI chrNW_004955495:4,800,103...4,807,714
Ensembl chrNW_004955495:4,799,922...4,807,252
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
disease_progression |
ISO |
protein:decreased expression:liver: |
RGD |
PMID:23936443 |
RGD:10401793 |
NCBI chrNW_004955424:27,181,717...27,240,067
Ensembl chrNW_004955424:27,181,099...27,240,446
|
|
G |
Eftud2 |
elongation factor Tu GTP binding domain containing 2 |
severity ameliorates |
ISO |
|
RGD |
PMID:34282556 |
RGD:155791664 |
NCBI chrNW_004955451:17,655,659...17,690,117
Ensembl chrNW_004955451:17,653,125...17,690,117
|
|
G |
Egf |
epidermal growth factor |
susceptibility |
ISO |
associated with hepatitis B;DNA:SNP:exon: (rs11569017) (human) CTD Direct Evidence: marker/mechanism associated with liver cirrhosis;DNA:SNP:5'UTR: (rs4444903) (human) |
RGD CTD |
PMID:9029167 PMID:18167406 PMID:23790025 |
RGD:14695013 RGD:14695014 |
NCBI chrNW_004955496:325,954...401,430
Ensembl chrNW_004955496:328,075...401,569
|
|
G |
Egfr |
epidermal growth factor receptor |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:9029167 PMID:11355950 |
RGD:126781769 |
NCBI chrNW_004955456:321,222...456,431
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955418:2,001,509...2,005,269
Ensembl chrNW_004955418:2,002,699...2,005,007
|
|
G |
Egr2 |
early growth response 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955425:16,055,748...16,068,429
Ensembl chrNW_004955425:16,055,748...16,060,048
|
|
G |
Ehd3 |
EH domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955469:12,953,800...12,984,296
Ensembl chrNW_004955469:12,953,645...12,984,430
|
|
G |
Eif3h |
eukaryotic translation initiation factor 3 subunit H |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14578863 |
|
NCBI chrNW_004955417:22,757,781...22,846,349
Ensembl chrNW_004955417:22,754,395...22,846,618
|
|
G |
Enah |
ENAH actin regulator |
disease_progression |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:35030977 |
RGD:155791678 |
NCBI chrNW_004955520:310,482...374,800
Ensembl chrNW_004955520:308,070...371,922
|
|
G |
Eng |
endoglin |
|
ISO |
protein:increased expression:liver (rat) |
RGD |
PMID:20368095 |
RGD:7257538 |
NCBI chrNW_004955419:818,797...853,319
Ensembl chrNW_004955419:818,932...852,694
|
|
G |
Eno1 |
enolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955486:4,275,371...4,287,152
Ensembl chrNW_004955486:4,274,238...4,289,809
|
|
G |
Ep300 |
E1A binding protein p300 |
|
ISO |
protein:increased expression:liver (rat) |
RGD |
PMID:17083329 |
RGD:2312274 |
NCBI chrNW_004955413:26,647,553...26,727,875
Ensembl chrNW_004955413:26,648,339...26,727,933
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26735578 |
|
NCBI chrNW_004955441:13,244,626...13,328,220
Ensembl chrNW_004955441:13,244,626...13,328,369
|
|
G |
Epcam |
epithelial cell adhesion molecule |
severity |
ISO |
protein:increased expression:liver |
RGD |
PMID:24616575 |
RGD:14695007 |
NCBI chrNW_004955441:14,155,084...14,167,584
Ensembl chrNW_004955441:14,155,082...14,169,161
|
|
G |
Ephb1 |
EPH receptor B1 |
|
ISO |
protein:increased phosphorylation:liver (mouse) |
RGD |
PMID:28100771 |
RGD:127285675 |
NCBI chrNW_004955501:3,424,112...3,821,727
Ensembl chrNW_004955501:3,423,977...3,821,890
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7892276 |
|
NCBI chrNW_004955520:116,363...142,983
Ensembl chrNW_004955520:116,363...128,665
|
|
G |
Epo |
erythropoietin |
disease_progression |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004955573:203,875...206,078
Ensembl chrNW_004955573:203,441...206,355
|
|
G |
Eps8l3 |
EPS8 signaling adaptor L3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955435:13,261,730...13,277,117
Ensembl chrNW_004955435:13,261,429...13,274,613
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
disease_progression |
ISO |
|
RGD |
PMID:11355950 |
RGD:126781769 |
NCBI chrNW_004955458:3,683,126...3,701,752
Ensembl chrNW_004955458:3,683,126...3,702,978
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
|
ISO |
DNA:insertion/deletion:3'UTR:rs6147150 (human) |
RGD |
PMID:22294845 |
RGD:126781763 |
NCBI chrNW_004955457:3,177,905...4,236,152
Ensembl chrNW_004955457:3,177,991...4,228,558
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
|
ISO |
mRNA, protein:increased expression:liver (human) |
RGD |
PMID:15922480 |
RGD:155598683 |
NCBI chrNW_004955555:2,393,510...2,430,180
Ensembl chrNW_004955555:2,393,278...2,406,582
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
susceptibility disease_progression |
ISO |
DNA:SNPs:exon 23: p.K751Q (rs13181) (human) DNA:SNP:cd: 312A>G (human) DNA:SNPs:exon 23: p.K751Q (human) DNA:SNPs:exon 23: p.K751Q (human) |
RGD |
PMID:19919686 PMID:25531380 PMID:28598207 PMID:28927037 |
RGD:150530503 RGD:25671459 RGD:25671460 RGD:25671461 |
NCBI chrNW_004955555:2,355,005...2,369,599
Ensembl chrNW_004955555:2,355,005...2,369,599
|
|
G |
Ereg |
epiregulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35776891 |
|
NCBI chrNW_004955474:612,440...627,606
Ensembl chrNW_004955474:612,440...627,606
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
ISO |
DNA:hypomethylation: CpG islands: |
RGD |
PMID:20165882 |
RGD:14694974 |
NCBI chrNW_004955478:7,720,664...7,803,662
Ensembl chrNW_004955478:7,751,830...7,799,460
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955482:8,572,227...8,579,589
Ensembl chrNW_004955482:8,572,227...8,579,946
|
|
G |
Esm1 |
endothelial cell specific molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955446:12,644,220...12,665,351
Ensembl chrNW_004955446:12,656,797...12,665,704
|
|
G |
Esr1 |
estrogen receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 PMID:28284560 |
|
NCBI chrNW_004955439:9,588,631...9,953,606
Ensembl chrNW_004955439:9,588,201...9,963,353
|
|
G |
Etfa |
electron transfer flavoprotein subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955450:1,392,526...1,451,591
Ensembl chrNW_004955450:1,392,479...1,451,591
|
|
G |
Exo1 |
exonuclease 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955406:10,248,981...10,276,207
Ensembl chrNW_004955406:10,245,886...10,275,522
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
susceptibility |
ISO |
mRNA:increased expression:liver (human) CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple |
RGD CTD |
PMID:24040354 PMID:24211739 PMID:25226601 PMID:26517514 PMID:28284560 PMID:34545456 More...
|
RGD:10755339 RGD:11537550 RGD:126779595 RGD:126779608 |
NCBI chrNW_004955491:4,215,353...4,292,229
Ensembl chrNW_004955491:4,215,298...4,292,235
|
|
G |
F2 |
coagulation factor II, thrombin |
severity |
ISO |
CTD Direct Evidence: marker/mechanism associated with liver cirrhosis;protein:altered expression, altered processing:liver (human) |
CTD RGD |
PMID:2821104 PMID:7620113 |
RGD:14975114 |
NCBI chrNW_004955422:1,356,675...1,367,788
Ensembl chrNW_004955422:1,356,769...1,367,517
|
|
G |
Fabp5 |
fatty acid binding protein 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955444:325,515...329,248
Ensembl chrNW_004955444:325,515...331,516
|
|
G |
Fam180a |
family with sequence similarity 180 member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955494:6,997,706...7,009,955
Ensembl chrNW_004955494:6,997,712...7,008,593
|
|
G |
Fam83d |
family with sequence similarity 83 member D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955445:17,837,099...17,861,421
Ensembl chrNW_004955445:17,836,938...17,861,397
|
|
G |
Fancd2 |
FA complementation group D2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955561:1,460,080...1,538,026
Ensembl chrNW_004955561:1,464,869...1,538,045
|
|
G |
Fanci |
FA complementation group I |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955416:15,788,812...15,857,933
Ensembl chrNW_004955416:15,788,922...15,853,480
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
protein:increased expression:liver: |
RGD |
PMID:11274632 PMID:29634416 PMID:30737368 |
RGD:13792608 RGD:14700677 RGD:14700700 |
NCBI chrNW_004955425:3,961,671...3,987,513
Ensembl chrNW_004955425:3,961,013...3,987,455
|
|
G |
Faslg |
Fas ligand |
|
ISO |
protein:increased expression:liver: |
RGD |
PMID:11274632 |
RGD:14700677 |
NCBI chrNW_004955406:13,098,479...13,107,045
Ensembl chrNW_004955406:13,098,662...13,107,389
|
|
G |
Fasn |
fatty acid synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14563831 PMID:15543204 PMID:21147110 |
|
NCBI chrNW_004955506:1,063,002...1,079,939
Ensembl chrNW_004955506:1,063,002...1,079,939
|
|
G |
Fat1 |
FAT atypical cadherin 1 |
disease_progression |
ISO |
mRNA,protein:increased expression:liver (human) |
RGD |
PMID:24590895 |
RGD:151347630 |
NCBI chrNW_004955403:22,502,625...22,618,513
Ensembl chrNW_004955403:22,502,625...22,619,211
|
|
G |
Fate1 |
fetal and adult testis expressed 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15580283 |
|
NCBI chrNW_004955498:7,237,494...7,241,447
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22039417 |
|
NCBI chrNW_004955422:21,537,337...21,569,174
Ensembl chrNW_004955422:21,536,667...21,569,433
|
|
G |
Fbxl18 |
F-box and leucine rich repeat protein 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955460:10,318,089...10,349,135
Ensembl chrNW_004955460:10,322,092...10,349,225
|
|
G |
Fbxo11 |
F-box protein 11 |
ameliorates exacerbates |
ISO |
mRNA:increased expression:liver (human) protein:increased expression:liver (human) |
RGD |
PMID:29518611 PMID:29603830 PMID:32657545 |
RGD:152025259 RGD:152025263 RGD:152025266 |
NCBI chrNW_004955441:14,471,283...14,495,508
Ensembl chrNW_004955441:14,471,283...14,553,916
|
|
G |
Fcn3 |
ficolin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955452:6,630,548...6,635,334
Ensembl chrNW_004955452:6,630,505...6,635,235
|
|
G |
Fdft1 |
farnesyl-diphosphate farnesyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21147110 |
|
NCBI chrNW_004955403:53,068,011...53,081,499
Ensembl chrNW_004955403:53,067,637...53,081,499
|
|
G |
Fes |
FES proto-oncogene, tyrosine kinase |
exacerbates |
ISO |
DNA:hypermethylation:promoter (human) |
RGD |
PMID:31038805 |
RGD:153323297 |
NCBI chrNW_004955416:14,948,121...14,959,035
Ensembl chrNW_004955416:14,948,123...14,960,005
|
|
G |
Fgf19 |
fibroblast growth factor 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25822088 |
|
NCBI chrNW_004955422:16,415,880...16,419,528
Ensembl chrNW_004955422:16,415,648...16,420,515
|
|
G |
Fgf3 |
fibroblast growth factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25822088 |
|
NCBI chrNW_004955422:16,333,363...16,339,853
Ensembl chrNW_004955422:16,333,363...16,339,853
|
|
G |
Fgf4 |
fibroblast growth factor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25822088 |
|
NCBI chrNW_004955422:16,362,418...16,364,126
|
|
G |
Fgfr1 |
fibroblast growth factor receptor 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16452204 PMID:20155451 PMID:21573021 PMID:36029209 |
RGD:25330358 RGD:25440476 RGD:25440478 |
NCBI chrNW_004955463:14,013,247...14,064,354
Ensembl chrNW_004955463:14,013,247...14,064,111
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
severity |
ISO |
associated with hepatitis B;DNA:SNPs: promoter, intron:rs308379, rs1219648 (human) |
RGD |
PMID:30952770 |
RGD:38501096 |
NCBI chrNW_004955551:2,321,190...2,427,000
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
treatment |
ISO |
|
RGD |
PMID:32677805 |
RGD:150520166 |
NCBI chrNW_004955408:29,370,480...29,383,531
Ensembl chrNW_004955408:29,370,468...29,383,971
|
|
G |
Fh |
fumarate hydratase |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma |
ClinVar |
PMID:10896297 PMID:15221078 PMID:16876016 PMID:17182618 PMID:18313410 PMID:19151755 PMID:20301679 PMID:21445611 PMID:25637381 PMID:25741868 PMID:28492532 PMID:28747166 More...
|
|
NCBI chrNW_004955406:10,535,801...10,558,649
Ensembl chrNW_004955406:10,535,323...10,561,627
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
|
ISO |
|
RGD |
PMID:12112319 |
RGD:632723 |
NCBI chrNW_004955430:221,518...508,094
|
|
G |
Flt3 |
fms related receptor tyrosine kinase 3 |
ameliorates |
ISO |
human cells in mouse model |
RGD |
PMID:27511526 |
RGD:149735514 |
NCBI chrNW_004955497:7,357,533...7,441,215
Ensembl chrNW_004955497:7,357,212...7,461,439
|
|
G |
Flvcr1 |
FLVCR choline and heme transporter 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955406:4,673,797...4,702,858
Ensembl chrNW_004955406:4,674,140...4,702,763
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9029167 PMID:28284560 |
|
NCBI chrNW_004955523:307,181...310,728
Ensembl chrNW_004955523:305,728...310,728
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955555:2,438,864...2,445,846
Ensembl chrNW_004955555:2,438,864...2,445,846
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
|
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:30086463 PMID:32048611 |
RGD:153344517 RGD:153344521 |
NCBI chrNW_004955469:10,297,179...10,319,180
Ensembl chrNW_004955469:10,297,179...10,319,180
|
|
G |
Foxa1 |
forkhead box A1 |
susceptibility sexual_dimorphism disease_progression |
ISO |
DNA:VNTR, SNPs, haplotypes:multiple: protein:decreased expression:liver |
RGD |
PMID:25965836 PMID:29208003 PMID:31400761 |
RGD:11054501 RGD:151665752 RGD:151665820 |
NCBI chrNW_004955409:23,598,127...23,599,827
Ensembl chrNW_004955409:23,598,127...23,599,461
|
|
G |
Foxm1 |
forkhead box M1 |
|
ISO |
CTD Direct Evidence: marker/mechanism OMIM:114550 |
CTD MouseDO |
PMID:15082532 PMID:17173139 PMID:28284560 |
|
NCBI chrNW_004955429:18,392,545...18,405,254
Ensembl chrNW_004955429:18,393,470...18,405,254
|
|
G |
Foxo1 |
forkhead box O1 |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:28972178 |
RGD:14401599 |
NCBI chrNW_004955431:5,797,359...5,890,758
|
|
G |
Foxp1 |
forkhead box P1 |
treatment |
ISO |
|
RGD |
PMID:25156538 |
RGD:9587823 |
NCBI chrNW_004955421:16,595,445...17,075,923
Ensembl chrNW_004955421:16,595,471...17,075,923
|
|
G |
Foxp3 |
forkhead box P3 |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:21086571 |
RGD:38548919 |
NCBI chrNW_004955543:731,707...742,606
Ensembl chrNW_004955543:731,707...742,606
|
|
G |
Fst |
follistatin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12203361 PMID:19363144 |
|
NCBI chrNW_004955446:13,925,833...13,932,104
Ensembl chrNW_004955446:13,925,776...13,932,104
|
|
G |
Fth1 |
ferritin heavy chain 1 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:9054589 |
RGD:632698 |
NCBI chrNW_004955511:5,772,374...5,773,224
Ensembl chrNW_004955511:5,771,777...5,773,112
|
|
G |
Fubp1 |
far upstream element binding protein 1 |
ameliorates exacerbates |
ISO |
associated with Chronic Hepatitis C;mRNA:increased expression:liver (human) human cell line in a mouse model |
RGD |
PMID:19637194 PMID:25995247 PMID:31587040 |
RGD:151361188 RGD:151361194 RGD:151361196 |
NCBI chrNW_004955423:15,245,645...15,278,628
Ensembl chrNW_004955423:15,245,610...15,278,628
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
treatment |
ISO |
associated with Glycogen Storage Disease IA, human gene in a mouse model |
RGD |
PMID:28096054 |
RGD:14695537 |
NCBI chrNW_004955451:16,672,512...16,680,001
Ensembl chrNW_004955451:16,672,979...16,680,001
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
disease_progression |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:25473368 PMID:35693827 |
RGD:10449118 RGD:153344586 |
NCBI chrNW_004955580:1,045,294...1,058,129
Ensembl chrNW_004955580:1,045,294...1,057,083
|
|
G |
Gabrd |
gamma-aminobutyric acid type A receptor subunit delta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955486:9,035,330...9,039,553
Ensembl chrNW_004955486:9,035,330...9,039,557
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16767786 PMID:21472284 |
|
NCBI chrNW_004955413:4,162,467...4,166,783
Ensembl chrNW_004955413:4,162,467...4,166,783
|
|
G |
Gc |
GC vitamin D binding protein |
susceptibility |
ISO |
protein:increased expression:liver associated with Hepatitis B, Chronic;DNA:SNP: :rs7041(human) |
RGD |
PMID:21683810 PMID:25541958 |
RGD:14402025 RGD:5509919 |
NCBI chrNW_004955447:1,361,698...1,400,633
Ensembl chrNW_004955447:1,361,566...1,402,491
|
|
G |
Gdf15 |
growth differentiation factor 15 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20512989 |
|
NCBI chrNW_004955524:3,123,513...3,125,642
Ensembl chrNW_004955524:3,123,760...3,125,621
|
|
G |
Gdf2 |
growth differentiation factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23936038 PMID:28284560 |
|
NCBI chrNW_004955556:2,204,841...2,210,335
Ensembl chrNW_004955556:2,205,071...2,209,055
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
disease_progression |
ISO |
RNA,protein:increased expression, activity:liver: HBV associated |
RGD |
PMID:10572675 PMID:11940314 PMID:27793641 |
RGD:14701040 RGD:14701041 RGD:14701048 |
NCBI chrNW_004955455:8,082,578...8,099,523
|
|
G |
Ghr |
growth hormone receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955426:26,553,509...26,873,619
Ensembl chrNW_004955426:26,689,581...26,871,684
|
|
G |
Gins1 |
GINS complex subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955415:31,341,021...31,363,069
Ensembl chrNW_004955415:31,341,021...31,367,135
|
|
G |
Gjb1 |
gap junction protein beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17978847 |
|
NCBI chrNW_004955475:10,779,415...10,787,910
Ensembl chrNW_004955475:10,785,996...10,787,910
|
|
G |
Gjb2 |
gap junction protein beta 2 |
|
ISO |
DNA, mRNA:promoter hypermethylation, decreased expression:liver |
RGD |
PMID:17295234 |
RGD:2289638 |
NCBI chrNW_004955497:987,213...989,477
Ensembl chrNW_004955497:988,422...989,099
|
|
G |
Gli1 |
GLI family zinc finger 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26189965 |
|
NCBI chrNW_004955458:5,181,761...5,193,500
Ensembl chrNW_004955458:5,185,225...5,193,196
|
|
G |
Glul |
glutamate-ammonia ligase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 |
|
NCBI chrNW_004955406:21,266,383...21,274,546
Ensembl chrNW_004955406:21,266,383...21,275,309
|
|
G |
Gmnn |
geminin DNA replication inhibitor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955483:2,283,518...2,344,982
Ensembl chrNW_004955483:2,282,485...2,293,924
|
|
G |
Gmps |
guanine monophosphate synthase |
|
ISO |
protein:increased activity:hepatoma (rat) |
RGD |
PMID:6861338 |
RGD:5135537 |
NCBI chrNW_004955448:6,931,891...6,984,662
Ensembl chrNW_004955448:6,932,926...6,984,662
|
|
G |
Gnao1 |
G protein subunit alpha o1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955433:14,004,813...14,170,631
Ensembl chrNW_004955433:14,004,813...14,172,707
|
|
G |
Gnaz |
G protein subunit alpha z |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955455:7,501,153...7,554,235
Ensembl chrNW_004955455:7,501,153...7,554,235
|
|
G |
Gnmt |
glycine N-methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism OMIM:114550 |
CTD MouseDO |
PMID:19146867 PMID:31086990 |
|
NCBI chrNW_004955437:8,944,288...8,946,642
Ensembl chrNW_004955437:8,944,047...8,946,642
|
|
G |
Golm1 |
golgi membrane protein 1 |
severity |
ISO |
protein:increased expression:serum mRNA, protein:increased expression:liver |
RGD |
PMID:21140449 PMID:21443671 |
RGD:401827118 RGD:401827119 |
NCBI chrNW_004955432:1,434,759...1,497,916
Ensembl chrNW_004955432:1,439,578...1,496,371
|
|
G |
Gpc1 |
glypican 1 |
disease_progression |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004955542:947,556...968,295
Ensembl chrNW_004955542:947,556...968,295
|
|
G |
Gpc3 |
glypican 3 |
disease_progression exacerbates severity treatment |
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:Peripheral Blood (human) protein:increased expression:blood serum (human) protein:increased expression:liver (human) mRNA,protein:increased expression:peripheral blood mononuclear cell,blood serum, liver (human) protein:increased expression:serum |
CTD RGD |
PMID:16698587 PMID:19496787 PMID:21438004 PMID:22883669 PMID:23558072 PMID:25449037 PMID:27286460 PMID:28284560 PMID:28801286 More...
|
RGD:14695019 RGD:14695020 RGD:243065125 RGD:243065131 RGD:243065134 RGD:243065135 RGD:243065139 |
NCBI chrNW_004955473:969,627...1,431,706
Ensembl chrNW_004955473:969,800...1,431,483
|
|
G |
Gpm6a |
glycoprotein M6A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955403:31,704,540...31,997,382
Ensembl chrNW_004955403:31,861,945...31,997,382
|
|
G |
Gpr158 |
G protein-coupled receptor 158 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955429:3,641,764...4,053,860
Ensembl chrNW_004955429:3,641,709...4,053,869
|
|
G |
Gpr182 |
G protein-coupled receptor 182 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955458:4,749,966...4,754,314
Ensembl chrNW_004955458:4,749,869...4,753,930
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
no_association susceptibility severity |
ISO |
associated with alcoholic liver cirrhosis;DNA:missense mutation:CDS:p.P198L (human) associated with hepatitis C;DNA:missense mutation:CDS:p.P198L (rs1050450) (human) |
RGD |
PMID:16510607 PMID:19929244 PMID:25894370 PMID:26990426 |
RGD:11533013 RGD:151708729 RGD:152995483 RGD:152998906 |
NCBI chrNW_004955532:1,298,336...1,298,830
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
severity disease_progression |
ISO |
mRNA,protein:decreased expression:liver, blood plasma (human) DNA:hypermethylation |
RGD |
PMID:25333265 PMID:25445749 PMID:27570561 |
RGD:151665355 RGD:151665509 RGD:401827855 |
NCBI chrNW_004955408:2,622,162...2,629,088
Ensembl chrNW_004955408:2,622,741...2,629,032
|
|
G |
Grb7 |
growth factor receptor bound protein 7 |
exacerbates |
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:17634422 |
RGD:151347655 |
NCBI chrNW_004955451:14,463,032...14,470,392
Ensembl chrNW_004955451:14,464,541...14,474,070
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
DNA:increased methylation:promoter CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:9029167 PMID:22536438 |
RGD:14401712 |
NCBI chrNW_004955422:17,914,228...17,916,918
Ensembl chrNW_004955422:17,914,305...17,917,428
|
|
G |
Gtse1 |
G2 and S-phase expressed 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955413:30,414,007...30,438,363
Ensembl chrNW_004955413:30,413,967...30,438,040
|
|
G |
Gys2 |
glycogen synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955413:17,182,342...17,240,180
Ensembl chrNW_004955413:17,178,983...17,240,213
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
|
ISO |
mRNA:decreased expression:liver (human) CTD Direct Evidence: marker/mechanism DNA:hypermethylation,hypomethylation:promoter |
RGD CTD |
PMID:28284560 PMID:29235098 |
RGD:15042879 |
NCBI chrNW_004955468:4,576,080...4,577,591
Ensembl chrNW_004955468:4,575,510...4,577,649
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955435:22,380,395...22,404,426
Ensembl chrNW_004955435:22,380,388...22,404,052
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
disease_progression |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004955408:11,047,679...11,070,492
|
|
G |
Havcr2 |
hepatitis A virus cellular receptor 2 |
disease_progression |
ISO |
associated with hepatitis B;DNA:SNP: : ���1516 G>T (human) |
RGD |
PMID:27034168 |
RGD:40818257 |
NCBI chrNW_004955408:11,289,920...11,311,216
Ensembl chrNW_004955408:11,291,937...11,311,320
|
|
G |
Hdac2 |
histone deacetylase 2 |
disease_progression |
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:24448241 |
RGD:9590206 |
NCBI chrNW_004955526:2,739,099...2,759,640
Ensembl chrNW_004955526:2,728,377...2,759,707
|
|
G |
Hdac4 |
histone deacetylase 4 |
|
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:21837748 |
RGD:9681451 |
NCBI chrNW_004955542:1,629,691...1,886,160
Ensembl chrNW_004955542:1,629,691...1,886,210
|
|
G |
Herc5 |
HECT and RLD domain containing E3 ubiquitin protein ligase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28919514 |
|
NCBI chrNW_004955474:11,954,915...11,991,849
|
|
G |
Hfe |
homeostatic iron regulator |
disease_progression |
ISO |
associated with Liver Cirrhosis;DNA:missense mutation:cds:p.C282Y (human) |
RGD |
PMID:20019189 PMID:29642405 |
RGD:14746967 RGD:2317357 |
NCBI chrNW_004955483:933,269...941,070
Ensembl chrNW_004955483:932,352...941,143
|
|
G |
Hgf |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9932610 PMID:11896611 |
|
NCBI chrNW_004955410:4,114,280...4,181,953
Ensembl chrNW_004955410:4,114,778...4,182,058
|
|
G |
Hgfac |
HGF activator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 |
|
NCBI chrNW_004955514:2,155,924...2,161,302
Ensembl chrNW_004955514:2,155,384...2,165,957
|
|
G |
Hhip |
hedgehog interacting protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18559595 |
|
NCBI chrNW_004955428:657,918...745,255
Ensembl chrNW_004955428:657,900...745,250
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
disease_progression treatment |
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:19335982 PMID:26078356 PMID:31321740 |
RGD:11526468 RGD:155882550 RGD:9068886 |
NCBI chrNW_004955466:8,000,311...8,022,497
Ensembl chrNW_004955466:8,000,044...8,022,497
|
|
G |
Hilpda |
hypoxia inducible lipid droplet associated |
disease_progression |
ISO |
mRNA:increased expression:liver (human) human cells in mouse model mRNA, protein:increased expression:liver (human) |
RGD |
PMID:30205391 PMID:31142329 PMID:35693827 |
RGD:153344574 RGD:153344577 RGD:153344586 |
NCBI chrNW_004955479:9,453,627...9,455,680
|
|
G |
Hjurp |
Holliday junction recognition protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955453:2,323,018...2,335,090
Ensembl chrNW_004955453:2,322,446...2,334,588
|
|
G |
Hmgb2 |
high mobility group box 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20851854 |
|
NCBI chrNW_004955403:33,656,314...33,659,115
Ensembl chrNW_004955403:33,656,300...33,659,428
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9207284 PMID:21147110 |
|
NCBI chrNW_004955425:25,362,165...25,380,611
Ensembl chrNW_004955425:25,359,884...25,380,745
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
disease_progression |
ISO |
|
RGD |
PMID:28867541 |
RGD:14975299 |
NCBI chrNW_004955435:22,804,484...22,820,807
Ensembl chrNW_004955435:22,804,484...22,821,482
|
|
G |
Hmmr |
hyaluronan mediated motility receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955408:16,865,066...16,895,918
Ensembl chrNW_004955408:16,865,175...16,898,328
|
|
G |
Hnf1a |
HNF1 homeobox A |
treatment |
ISO |
human cell line in mouse model |
RGD |
PMID:29466992 |
RGD:14700664 |
NCBI chrNW_004955455:10,694,102...10,717,613
Ensembl chrNW_004955455:10,694,102...10,717,613
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4 alpha |
|
ISO |
protein:decreased expression:liver: |
RGD |
PMID:20876809 |
RGD:12904747 |
NCBI chrNW_004955445:12,925,248...12,962,501
Ensembl chrNW_004955445:12,924,662...12,984,281
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:23633480 |
RGD:9685423 |
NCBI chrNW_004955458:1,530,163...1,536,874
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
|
ISO |
mRNA:increased expression:liver (rat) protein:increased expression:liver (human) |
RGD |
PMID:20604928 PMID:23633480 |
RGD:9685422 RGD:9685423 |
NCBI chrNW_004955410:28,032,193...28,042,459
Ensembl chrNW_004955410:28,032,193...28,042,459
|
|
G |
Hnrnpab |
heterogeneous nuclear ribonucleoprotein A/B |
severity |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:24638979 |
RGD:10059322 |
NCBI chrNW_004955408:2,060,288...2,064,998
Ensembl chrNW_004955408:2,060,829...2,065,416
|
|
G |
Hnrnpd |
heterogeneous nuclear ribonucleoprotein D |
|
ISO |
protein:increased expression:liver (human) protein:increased expression:liver (rat) |
RGD |
PMID:20102719 PMID:22318685 |
RGD:10042969 RGD:10042977 |
NCBI chrNW_004955433:6,452,931...6,470,209
Ensembl chrNW_004955433:6,454,454...6,469,904
|
|
G |
Hnrnph1 |
heterogeneous nuclear ribonucleoprotein H1 |
|
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:23633480 |
RGD:9685423 |
NCBI chrNW_004955408:937,706...944,969
Ensembl chrNW_004955408:936,595...948,064
|
|
G |
Hnrnpl |
heterogeneous nuclear ribonucleoprotein L |
|
ISO |
associated with Hepatitis B |
RGD |
PMID:24125732 |
RGD:9999429 |
NCBI chrNW_004955468:668,177...683,540
Ensembl chrNW_004955468:670,559...683,540
|
|
G |
Hoxa10 |
homeobox A10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955410:28,864,785...28,874,454
Ensembl chrNW_004955410:28,864,785...28,874,454
|
|
G |
Hoxa13 |
homeobox A13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955410:28,887,952...28,893,515
Ensembl chrNW_004955410:28,890,171...28,893,515
|
|
G |
Hoxd9 |
homeobox D9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955451:12,619,722...12,621,320
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
ISO |
protein:increased activity:hepatoma (rat) |
RGD |
PMID:6327016 |
RGD:5135035 |
NCBI chrNW_004955473:462,940...510,006
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
treatment |
ISO |
human cells in a mouse model ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma |
RGD ClinVar |
PMID:10791191 PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 More...
|
RGD:14688055 |
NCBI chrNW_004955476:11,508,446...11,510,333
Ensembl chrNW_004955476:11,508,126...11,510,333
|
|
G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 |
|
NCBI chrNW_004955435:22,414,605...22,421,682
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 PMID:29698666 |
|
NCBI chrNW_004955419:3,055,420...3,060,208
Ensembl chrNW_004955419:3,055,420...3,062,131
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955418:1,915,985...1,931,017
Ensembl chrNW_004955418:1,915,985...1,931,017
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955844:8,094...9,565
Ensembl chrNW_004955844:7,790...10,004
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16799960 |
|
NCBI chrNW_004955476:1,197,053...1,219,679
Ensembl chrNW_004955476:1,196,986...1,222,730
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
disease_progression exacerbates |
ISO |
mRNA:decreased expression:liver (human) protein:decreased expression:liver (human) |
RGD |
PMID:20943460 PMID:26403966 |
RGD:152985524 RGD:152985529 |
NCBI chrNW_004955477:761,127...808,396
Ensembl chrNW_004955477:761,127...808,994
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
severity |
ISO |
protein:increased expression:serum |
RGD |
PMID:26109813 |
RGD:11056752 |
NCBI chrNW_004955495:1,561,464...1,573,282
Ensembl chrNW_004955495:1,561,714...1,574,755
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955457:6,851,542...6,869,452
Ensembl chrNW_004955457:6,851,517...6,872,367
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
disease_progression |
ISO |
|
RGD |
PMID:24716838 |
RGD:14985249 |
NCBI chrNW_004955416:15,197,611...15,212,919
Ensembl chrNW_004955416:15,197,366...15,223,363
|
|
G |
Ier2 |
immediate early response 2 |
|
ISO |
mRNA, protein:decreased expression:liver (human) |
RGD |
PMID:32009420 |
RGD:153323326 |
NCBI chrNW_004955415:32,159,762...32,161,530
Ensembl chrNW_004955415:32,159,935...32,160,624
|
|
G |
Ifng |
interferon gamma |
|
ISO |
mRNA:increased expression:liver (mouse) |
RGD |
PMID:26569409 |
RGD:11344640 |
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
|
|
G |
Igbp1 |
immunoglobulin binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21339737 |
|
NCBI chrNW_004955475:9,671,162...9,694,926
|
|
G |
Igf1 |
insulin like growth factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955405:37,505,830...37,582,152
Ensembl chrNW_004955405:37,512,201...37,582,152
|
|
G |
Igf1r |
insulin like growth factor 1 receptor |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNPs, haplotype: : |
CTD RGD |
PMID:17441810 PMID:23958494 PMID:24758241 |
RGD:14985227 |
NCBI chrNW_004955416:26,101,090...26,382,660
Ensembl chrNW_004955416:26,102,628...26,382,666
|
|
G |
Igf2 |
insulin like growth factor 2 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism associated with hepatitis B;DNA:SNPs:intron, 3'utr:+2482A>C, +820A>G (human) |
RGD CTD |
PMID:12532445 PMID:16092956 PMID:16750516 PMID:17554210 |
RGD:14401723 RGD:2311523 |
NCBI chrNW_004955422:13,880,525...13,907,963
Ensembl chrNW_004955422:13,880,471...13,888,566
|
|
G |
Igf2bp1 |
insulin like growth factor 2 mRNA binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955451:12,312,715...12,348,663
Ensembl chrNW_004955451:12,312,715...12,348,663
|
|
G |
Igf2bp3 |
insulin like growth factor 2 mRNA binding protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955410:25,605,323...25,734,845
Ensembl chrNW_004955410:25,605,323...25,731,169
|
|
G |
Igf2r |
insulin like growth factor 2 receptor |
treatment disease_progression no_association |
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma DNA:loss of heterozygosity:liver DNA:loss of heterozygosity,mutations:liver: |
OMIM ClinVar RGD |
PMID:9722161 PMID:10347113 PMID:18322954 PMID:25741868 PMID:30720132 |
RGD:14985219 RGD:14985220 RGD:14985221 |
NCBI chrNW_004955439:20,754,915...20,874,759
Ensembl chrNW_004955439:20,752,855...20,851,281
|
|
G |
Igfals |
insulin like growth factor binding protein acid labile subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955442:15,469,602...15,482,115
Ensembl chrNW_004955442:15,478,202...15,482,115
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
treatment |
ISO |
protein:decreased expression:liver (human) |
RGD |
PMID:17292824 PMID:22176836 PMID:22922425 PMID:24971483 PMID:25173965 PMID:29551768 More...
|
RGD:11079569 RGD:153297807 RGD:153297813 RGD:153305943 RGD:153305945 RGD:153305947 |
NCBI chrNW_004955580:1,053,823...1,069,802
Ensembl chrNW_004955580:1,053,823...1,069,802
|
|
G |
Ikzf1 |
IKAROS family zinc finger 1 |
ameliorates |
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:25301737 |
RGD:150540326 |
NCBI chrNW_004955456:3,617,988...3,721,791
Ensembl chrNW_004955456:3,635,380...3,721,791
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
|
RGD |
PMID:23822114 PMID:26890368 |
RGD:14975171 RGD:7365006 |
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
|
|
G |
Il12a |
interleukin 12A |
susceptibility |
ISO |
associated with hepatitis B; DNA:SNP, haplotype:3′UTR :rs568408(human) associated with hepatitis C;DNA:SNP:3'UTR: rs568408( G>A)(human) |
RGD |
PMID:20521253 PMID:26631030 PMID:27819525 |
RGD:25440490 RGD:25440491 RGD:25440501 |
NCBI chrNW_004955448:10,611,131...10,617,911
|
|
G |
Il15ra |
interleukin 15 receptor subunit alpha |
disease_progression |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004955421:22,590,168...22,612,835
Ensembl chrNW_004955421:22,586,012...22,620,788
|
|
G |
Il18 |
interleukin 18 |
disease_progression severity susceptibility |
ISO |
associated with hepatitis C;DNA:SNPs, haplotype:promoter:-607C>A, -137G>C(human) associated with hepatitis B, chronic;DNA:SNP:promoter:-607C>A(human) DNA:SNP:promoter:-137G>C(rs187238)(human) |
RGD |
PMID:26893476 PMID:27429592 PMID:27470888 PMID:29341496 |
RGD:11538094 RGD:14695526 RGD:14695540 RGD:14696663 |
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
|
|
G |
Il18r1 |
interleukin 18 receptor 1 |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:26893476 |
RGD:11538094 |
NCBI chrNW_004955470:7,854,995...7,887,810
Ensembl chrNW_004955470:7,854,988...7,887,883
|
|
G |
Il1b |
interleukin 1 beta |
susceptibility |
ISO |
DNA:polymorphism:promoter:-31T>C (human) |
RGD |
PMID:21653279 |
RGD:7401222 |
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Il1rap |
interleukin 1 receptor accessory protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955420:17,463,493...17,591,054
Ensembl chrNW_004955420:17,463,852...17,591,023
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955470:1,145,022...1,159,413
Ensembl chrNW_004955470:1,144,810...1,159,471
|
|
G |
Il2 |
interleukin 2 |
treatment |
ISO |
|
RGD |
PMID:9449371 PMID:10933975 |
RGD:14747035 RGD:8693323 |
NCBI chrNW_004955428:18,163,010...18,168,157
Ensembl chrNW_004955428:18,162,467...18,168,265
|
|
G |
Il21 |
interleukin 21 |
|
ISO |
associated with hepatitis B;DNA:SNPS, haplotype:(rs13143866, rs2221903, rs907715) (human) |
RGD |
PMID:25892873 |
RGD:127285359 |
NCBI chrNW_004955428:18,057,096...18,065,492
Ensembl chrNW_004955428:18,057,096...18,065,492
|
|
G |
Il6 |
interleukin 6 |
treatment disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:liver, blood serum (mouse) DNA:SNP: :rs2069852 (human) |
CTD RGD |
PMID:17615358 PMID:20818158 PMID:26297436 PMID:26569409 PMID:27022031 PMID:27368337 PMID:29486150 More...
|
RGD:11344640 RGD:127285672 RGD:14975289 |
NCBI chrNW_004955410:25,079,835...25,084,390
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
|
ISO |
|
RGD |
PMID:15780071 |
RGD:1626706 |
NCBI chrNW_004955446:11,790,636...11,837,734
Ensembl chrNW_004955446:11,790,444...11,835,001
|
|
G |
Ing3 |
inhibitor of growth family member 3 |
treatment |
ISO |
|
RGD |
PMID:25156538 |
RGD:9587823 |
NCBI chrNW_004955479:2,741,554...2,771,524
Ensembl chrNW_004955479:2,743,655...2,774,247
|
|
G |
Inpp4b |
inositol polyphosphate-4-phosphatase type II B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29415082 |
|
NCBI chrNW_004955471:938,005...1,291,695
Ensembl chrNW_004955471:938,005...1,291,695
|
|
G |
Ins |
insulin |
|
ISO |
associated with Chronic Hepatitis C;mRNA:decreased expression:liver (human) |
RGD |
PMID:33132693 |
RGD:150340613 |
NCBI chrNW_004955422:13,909,408...13,910,419
Ensembl chrNW_004955422:13,909,407...13,910,419
|
|
G |
Insr |
insulin receptor |
|
ISO |
human cells in a mouse model mRNA, protein:increased expression:liver (human, rat) |
RGD |
PMID:23633480 PMID:29610518 |
RGD:14700930 RGD:9685423 |
NCBI chrNW_004955563:1,867,400...2,011,845
Ensembl chrNW_004955563:1,867,400...2,009,149
|
|
G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20977743 |
|
NCBI chrNW_004955416:14,558,628...14,652,031
Ensembl chrNW_004955416:14,560,292...14,650,036
|
|
G |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism OMIM:114550 |
CTD MouseDO |
PMID:20977743 |
|
NCBI chrNW_004955425:24,167,985...24,384,912
Ensembl chrNW_004955425:24,167,104...24,385,146
|
|
G |
Iqgap3 |
IQ motif containing GTPase activating protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955545:2,627,334...2,663,786
Ensembl chrNW_004955545:2,628,552...2,663,737
|
|
G |
Irf2 |
interferon regulatory factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561517 |
|
NCBI chrNW_004955403:24,433,334...24,517,618
Ensembl chrNW_004955403:24,433,258...24,517,618
|
|
G |
Irs1 |
insulin receptor substrate 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:1311924 PMID:23958494 |
|
NCBI chrNW_004955453:7,685,715...7,742,262
Ensembl chrNW_004955453:7,685,715...7,742,262
|
|
G |
Irs2 |
insulin receptor substrate 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16127164 |
|
NCBI chrNW_004955404:2,531,484...2,555,383
Ensembl chrNW_004955404:2,531,484...2,555,689
|
|
G |
Isg15 |
ISG15 ubiquitin like modifier |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28919514 |
|
NCBI chrNW_004955486:9,706,878...9,707,876
Ensembl chrNW_004955486:9,706,703...9,707,949
|
|
G |
Itih3 |
inter-alpha-trypsin inhibitor heavy chain 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 |
|
NCBI chrNW_004955430:2,753,974...2,767,436
Ensembl chrNW_004955430:2,753,996...2,767,324
|
|
G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
disease_progression |
ISO |
associated with hepatitis B;protein:decreased expression:serum |
RGD |
PMID:24836184 |
RGD:40903002 |
NCBI chrNW_004955430:2,772,064...2,787,912
Ensembl chrNW_004955430:2,770,373...2,789,131
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:30660174 |
RGD:14694832 |
NCBI chrNW_004955415:20,490,414...20,526,068
Ensembl chrNW_004955415:20,490,414...20,527,917
|
|
G |
Jak1 |
Janus kinase 1 |
|
ISO |
|
RGD |
PMID:23788652 |
RGD:150524353 |
NCBI chrNW_004955423:25,501,989...25,581,826
Ensembl chrNW_004955423:25,524,075...25,580,604
|
|
G |
Jak2 |
Janus kinase 2 |
severity treatment ameliorates exacerbates |
ISO |
mRNA:decreased expression:liver (human) L-JAK2 KO protein:increased phosphorylation:liver (mouse) associated with Diseases of the Aged and non-alcoholic fatty liver disease protein:increased phosphorylation:liver (human) |
RGD |
PMID:22392353 PMID:22821478 PMID:25420511 PMID:28100771 PMID:29486150 PMID:31393852 More...
|
RGD:125097525 RGD:127285621 RGD:127285655 RGD:127285672 RGD:127285675 RGD:18182928 |
NCBI chrNW_004955434:9,227,897...9,341,208
Ensembl chrNW_004955434:9,227,595...9,341,208
|
|
G |
Jdp2 |
Jun dimerization protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20214788 |
|
NCBI chrNW_004955523:140,546...169,769
Ensembl chrNW_004955523:140,546...169,775
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20214788 |
|
NCBI chrNW_004955464:1,107,598...1,110,326
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
associated with HBV;protein:increased expression:liver (human) |
RGD |
PMID:15927205 |
RGD:153297768 |
NCBI chrNW_004955524:3,176,849...3,177,936
|
|
G |
Kat2b |
lysine acetyltransferase 2B |
severity |
ISO |
protein:decreased expression:liver (human) |
RGD |
PMID:23643089 |
RGD:9590314 |
NCBI chrNW_004955430:12,109,493...12,196,102
Ensembl chrNW_004955430:12,128,069...12,198,117
|
|
G |
Kbtbd11 |
kelch repeat and BTB domain containing 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955403:57,796,246...57,818,666
|
|
G |
Kcnh1 |
potassium voltage-gated channel subfamily H member 1 |
|
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:17022810 |
RGD:9693723 |
NCBI chrNW_004955489:1,176,615...1,549,880
Ensembl chrNW_004955489:1,179,053...1,545,355
|
|
G |
Kcnn2 |
potassium calcium-activated channel subfamily N member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955408:34,223,523...34,366,191
Ensembl chrNW_004955408:34,109,334...34,368,114
|
|
G |
Kdm1a |
lysine demethylase 1A |
severity |
ISO |
mRNA, protein:increased expression:liver (human) |
RGD |
PMID:23236241 |
RGD:9681002 |
NCBI chrNW_004955452:3,044,042...3,104,650
Ensembl chrNW_004955452:3,044,264...3,104,418
|
|
G |
Kdm3a |
lysine demethylase 3A |
|
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:21607773 |
RGD:9590222 |
NCBI chrNW_004955424:1,164,384...1,218,607
Ensembl chrNW_004955424:1,171,827...1,218,607
|
|
G |
Kdm5c |
lysine demethylase 5C |
exacerbates |
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:26503415 |
RGD:11530160 |
NCBI chrNW_004955475:243,666...278,064
Ensembl chrNW_004955475:243,666...278,627
|
|
G |
Kdm6a |
lysine demethylase 6A |
ameliorates |
ISO |
human cells in a mouse model |
RGD |
PMID:32765772 |
RGD:150429729 |
NCBI chrNW_004955516:3,151,350...3,346,832
Ensembl chrNW_004955516:3,149,948...3,346,832
|
|
G |
Kdm8 |
lysine demethylase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955493:5,437,344...5,462,849
Ensembl chrNW_004955493:5,437,090...5,462,294
|
|
G |
Kdr |
kinase insert domain receptor |
disease_progression treatment |
ISO |
protein:decreased expression:liver associated with alcoholic liver cirrhosis;DNA:SNP: :1416A>T (human) protein:increased expression:liver DNA:SNPs: :rs1870377, rs2071559, rs2305948 (human) |
RGD |
PMID:19177438 PMID:23660204 PMID:24445728 PMID:25182707 PMID:25333267 |
RGD:126848806 RGD:126848810 RGD:126848812 RGD:126848813 RGD:126848814 |
NCBI chrNW_004955447:15,810,816...15,851,702
Ensembl chrNW_004955447:15,810,815...15,853,583
|
|
G |
Kif11 |
kinesin family member 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955425:764,382...804,856
Ensembl chrNW_004955425:763,868...804,583
|
|
G |
Kif14 |
kinesin family member 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955406:36,732,135...36,791,756
Ensembl chrNW_004955406:36,737,484...36,791,756
|
|
G |
Kif15 |
kinesin family member 15 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955420:26,774,506...26,828,301
Ensembl chrNW_004955420:26,775,120...26,827,660
|
|
G |
Kif18a |
kinesin family member 18A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955476:7,058,682...7,117,496
Ensembl chrNW_004955476:7,058,573...7,109,610
|
|
G |
Kif18b |
kinesin family member 18B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955451:17,707,150...17,722,376
Ensembl chrNW_004955451:17,706,661...17,722,433
|
|
G |
Kif1b |
kinesin family member 1B |
susceptibility severity |
ISO |
DNA:snp:intron:c.2537+518A>G (rs17401966) (human) mRNA, protein:decreased expression:liver (human) |
RGD |
PMID:26217094 PMID:27122668 |
RGD:11052488 RGD:12738461 |
NCBI chrNW_004955486:3,366,791...3,503,845
Ensembl chrNW_004955486:3,370,596...3,489,052
|
|
G |
Kif20a |
kinesin family member 20A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955418:2,222,398...2,232,775
Ensembl chrNW_004955418:2,222,398...2,232,775
|
|
G |
Kif23 |
kinesin family member 23 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955450:7,060,240...7,083,818
Ensembl chrNW_004955450:7,060,823...7,082,169
|
|
G |
Kif2c |
kinesin family member 2C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955464:13,453,637...13,475,447
Ensembl chrNW_004955464:13,453,217...13,475,322
|
|
G |
Kif4a |
kinesin family member 4A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955475:9,845,633...9,969,965
Ensembl chrNW_004955475:9,845,633...9,970,564
|
|
G |
Kifc1 |
kinesin family member C1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955437:1,923,136...1,941,094
Ensembl chrNW_004955437:1,923,506...1,940,970
|
|
G |
Klf4 |
KLF transcription factor 4 |
treatment disease_progression |
ISO |
|
RGD |
PMID:22677193 |
RGD:14402023 |
NCBI chrNW_004955419:19,280,311...19,284,097
Ensembl chrNW_004955419:19,280,235...19,285,174
|
|
G |
Kmt2a |
lysine methyltransferase 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22634756 |
|
NCBI chrNW_004955412:19,586,435...19,670,149
Ensembl chrNW_004955412:19,586,141...19,665,527
|
|
G |
Kmt2b |
lysine methyltransferase 2B |
|
ISO |
DNA:insertions, translocations:intron:IVS3, multiple (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:18320596 PMID:22634754 |
RGD:9588597 |
NCBI chrNW_004955468:2,813,183...2,834,326
Ensembl chrNW_004955468:2,813,496...2,834,326
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22634756 |
|
NCBI chrNW_004955491:6,245,408...6,420,535
Ensembl chrNW_004955491:6,247,249...6,402,470
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
induced |
ISO |
aflatoxin B1 induced:DNA:transversion,transition mutations:cds: mRNA,protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:8446626 PMID:11286481 PMID:11563603 PMID:29275358 |
RGD:11568697 RGD:14398750 |
NCBI chrNW_004955413:20,298,852...20,328,756
Ensembl chrNW_004955413:20,298,824...20,328,758
|
|
G |
Krt18 |
keratin 18 |
|
ISO |
OMIM:114550 |
MouseDO |
|
|
NCBI chrNW_004955458:227,017...230,752
Ensembl chrNW_004955458:226,805...232,728
|
|
G |
Lcat |
lecithin-cholesterol acyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955484:8,772,692...8,776,122
Ensembl chrNW_004955484:8,772,692...8,776,122
|
|
G |
Lect2 |
leukocyte cell derived chemotaxin 2 |
ameliorates |
ISO |
human cells in mouse model protein:increased expression:blood serum (human) protein:increased expression:blood serum (mouse) |
RGD |
PMID:21394108 PMID:24892551 |
RGD:153323333 RGD:153323335 |
NCBI chrNW_004955408:31,016,955...31,068,998
Ensembl chrNW_004955408:31,016,815...31,025,093
|
|
G |
Lep |
leptin |
susceptibility severity |
ISO |
DNA:SNP:enhancer:-2548G>A (rs7799039) (human) protein:increased expression:liver (human) |
RGD |
PMID:18573568 PMID:28452232 |
RGD:15039399 RGD:25330348 |
NCBI chrNW_004955479:9,266,604...9,276,568
Ensembl chrNW_004955479:9,274,516...9,279,472
|
|
G |
Lepr |
leptin receptor |
susceptibility |
ISO |
associated with Hepatitis B, Chronic;DNA:missense mutations:cds:p.Q223R, p.K109R (human) |
RGD |
PMID:23090836 |
RGD:21079466 |
NCBI chrNW_004955423:25,108,897...25,185,315
Ensembl chrNW_004955423:25,111,266...25,185,407
|
|
G |
Letm1 |
leucine zipper and EF-hand containing transmembrane protein 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23392203 |
|
NCBI chrNW_004955514:1,040,103...1,069,297
Ensembl chrNW_004955514:1,042,307...1,069,114
|
|
G |
Lifr |
LIF receptor subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955426:23,045,867...23,093,694
Ensembl chrNW_004955426:23,047,167...23,116,891
|
|
G |
LOC102006164 |
24-hydroxycholesterol 7-alpha-hydroxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955437:11,444,780...11,497,268
Ensembl chrNW_004955437:11,444,220...11,497,084
|
|
G |
LOC102010322 |
cytochrome P450 1A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955450:3,165,107...3,171,894
Ensembl chrNW_004955450:3,165,106...3,171,942
|
|
G |
LOC102010850 |
cytochrome P450 1A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15341023 |
|
NCBI chrNW_004955450:3,183,958...3,189,488
Ensembl chrNW_004955450:3,183,750...3,189,488
|
|
G |
LOC102011010 |
steroid 17-alpha-hydroxylase/17,20 lyase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15341023 |
|
NCBI chrNW_004955485:7,615,132...7,652,899
Ensembl chrNW_004955485:7,645,363...7,650,658
|
|
G |
LOC102021597 |
alpha-1-antiproteinase S-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:6258829 PMID:21472284 |
|
NCBI chrNW_004955438:17,920,200...17,929,105
|
|
G |
LOC102021956 |
alpha-2-macroglobulin |
|
ISO |
mRNA,protein:increased expression:liver: CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:15509519 |
RGD:1358261 |
NCBI chrNW_004955413:6,019,457...6,062,366
Ensembl chrNW_004955413:6,019,082...6,062,529
|
|
G |
LOC102023166 |
cytochrome P450 26B1 |
disease_progression |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004955424:13,336,189...13,355,368
Ensembl chrNW_004955424:13,336,189...13,355,423
|
|
G |
LOC102023269 |
calmodulin-like protein 3 |
severity |
ISO |
protein:decreased expression:liver (human) |
RGD |
PMID:29445139 |
RGD:151665319 |
NCBI chrNW_004955421:22,205,476...22,219,715
Ensembl chrNW_004955421:22,214,339...22,219,715
|
|
G |
LOC102023845 |
chromosome unknown open reading frame, human C14orf180 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955538:3,076,578...3,083,867
Ensembl chrNW_004955538:3,080,112...3,082,282
|
|
G |
LOC102025724 |
HLA class II histocompatibility antigen, DP alpha 1 chain |
|
ISO |
DNA:hypomethylation: CpG islands: |
RGD |
PMID:20165882 |
RGD:14694974 |
NCBI chrNW_004955437:1,644,037...1,657,094
Ensembl chrNW_004955437:1,643,238...1,651,071
|
|
G |
LOC102026028 |
cytochrome P450 2E1 |
|
ISO |
associated with alcohol dependence CTD Direct Evidence: marker/mechanism DNA, mRNA:SNP, Decreased expression:liver: rs2031920 (human) |
RGD CTD |
PMID:15162526 PMID:20364586 PMID:29765251 |
RGD:14700882 RGD:14700899 |
NCBI chrNW_004955507:6,293,162...6,303,255
Ensembl chrNW_004955507:6,289,576...6,304,193
|
|
G |
LOC102030009 |
cytochrome c oxidase subunit 7B2, mitochondrial |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955443:1,650,087...1,768,318
|
|
G |
Loxl3 |
lysyl oxidase like 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35841383 |
|
NCBI chrNW_004955424:11,236,415...11,255,801
Ensembl chrNW_004955424:11,236,836...11,259,570
|
|
G |
Lpar1 |
lysophosphatidic acid receptor 1 |
|
ISO |
|
RGD |
PMID:19000703 |
RGD:2317680 |
NCBI chrNW_004955419:16,190,109...16,324,702
Ensembl chrNW_004955419:16,191,244...16,325,602
|
|
G |
Lrat |
lecithin retinol acyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955471:2,603,395...2,610,988
Ensembl chrNW_004955471:2,603,678...2,609,079
|
|
G |
Lrp1b |
LDL receptor related protein 1B |
exacerbates |
ISO |
protein:increased expression:liver (human) DNA:mutations:multiple: (human) |
RGD |
PMID:33324588 PMID:33391418 |
RGD:150429776 RGD:150429785 |
NCBI chrNW_004955440:7,048,527...8,475,566
Ensembl chrNW_004955440:7,050,135...8,475,122
|
|
G |
Lrrc1 |
leucine rich repeat containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955411:2,189,882...2,259,733
Ensembl chrNW_004955411:2,188,803...2,259,781
|
|
G |
Lrrc56 |
leucine rich repeat containing 56 |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma |
ClinVar |
PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20301680 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31222966 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 More...
|
|
NCBI chrNW_004955476:11,493,299...11,507,022
Ensembl chrNW_004955476:11,491,688...11,506,700
|
|
G |
Lrrc59 |
leucine rich repeat containing 59 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chrNW_004955451:11,316,139...11,328,107
Ensembl chrNW_004955451:11,315,725...11,332,394
|
|
G |
Lyve1 |
lymphatic vessel endothelial hyaluronan receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955414:26,161,768...26,175,621
Ensembl chrNW_004955414:26,160,605...26,175,891
|
|
G |
Lztr1 |
leucine zipper like post translational regulator 1 |
|
ISO |
DNA:missense mutation:cds, liver (human) |
RGD |
PMID:28622513 |
RGD:151893487 |
NCBI chrNW_004955442:19,315,427...19,333,361
Ensembl chrNW_004955442:19,315,427...19,333,522
|
|
G |
Mad2l1 |
mitotic arrest deficient 2 like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 PMID:39316419 |
|
NCBI chrNW_004955428:20,421,718...20,443,394
Ensembl chrNW_004955428:20,421,723...20,430,307
|
|
G |
Map2k2 |
mitogen-activated protein kinase kinase 2 |
exacerbates |
ISO |
protein:increased expression:liver, cytosol (rat) mRNA:increased expression:liver (human) |
RGD |
PMID:9397988 PMID:33553243 |
RGD:150530475 RGD:150530477 |
NCBI chrNW_004955495:4,695,239...4,718,380
Ensembl chrNW_004955495:4,695,768...4,722,098
|
|
G |
Map2k4 |
mitogen-activated protein kinase kinase 4 |
|
ISO |
protein:decreased expression:liver (human) |
RGD |
PMID:32850377 |
RGD:150429765 |
NCBI chrNW_004955467:5,188,036...5,295,570
Ensembl chrNW_004955467:5,187,356...5,307,692
|
|
G |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
exacerbates |
ISO |
mRNA:decreased expression:liver (human) |
RGD |
PMID:31310010 |
RGD:150573714 |
NCBI chrNW_004955446:11,022,091...11,090,136
Ensembl chrNW_004955446:11,021,971...11,090,136
|
|
G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
ameliorates |
ISO |
|
RGD |
PMID:26560698 |
RGD:11342977 |
NCBI chrNW_004955429:21,717,153...21,739,349
Ensembl chrNW_004955429:21,716,958...21,741,585
|
|
G |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
treatment ameliorates severity |
ISO |
human cell line in a mouse model human recombinant gene and cell line in a mouse model |
RGD |
PMID:21196414 PMID:27010469 PMID:31922225 |
RGD:151347673 RGD:151347674 RGD:151347839 |
NCBI chrNW_004955470:7,334,050...7,470,751
Ensembl chrNW_004955470:7,333,351...7,470,751
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:27468214 |
RGD:401976278 |
NCBI chrNW_004955442:17,284,232...17,380,026
Ensembl chrNW_004955442:17,284,232...17,380,020
|
|
G |
Mapk14 |
mitogen-activated protein kinase 14 |
treatment exacerbates |
ISO |
|
RGD |
PMID:23271722 PMID:25216638 |
RGD:151665347 RGD:151665348 |
NCBI chrNW_004955437:3,836,331...3,884,083
Ensembl chrNW_004955437:3,838,232...3,884,083
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
ameliorates |
ISO |
protein:decreased phosphorylation:liver (human) |
RGD |
PMID:33875785 |
RGD:150340688 |
NCBI chrNW_004955556:1,593,552...1,705,543
Ensembl chrNW_004955556:1,593,494...1,665,784
|
|
G |
Mapt |
microtubule associated protein tau |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955478:10,222,439...10,271,439
Ensembl chrNW_004955478:10,225,823...10,271,442
|
|
G |
Marco |
macrophage receptor with collagenous structure |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955459:10,700,645...10,739,222
Ensembl chrNW_004955459:10,698,294...10,739,131
|
|
G |
Mat1a |
methionine adenosyltransferase 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12060674 |
|
NCBI chrNW_004955510:283,860...300,991
Ensembl chrNW_004955510:281,331...300,985
|
|
G |
Mbl2 |
mannose binding lectin 2 |
susceptibility severity no_association |
ISO |
associated with hepatitis B-related cirrhosis;DNA:SNP: :rs11003123(G>A)(human) DNA:SNPs:promoter:rs7096206(human) associated with hepatitis C;DNA:SNP: :221C>G(rs709620)(human) associated with viral hepatitis;DNA:polymorphisms:exon: associated with hepatitis B;DNA:SNP:exon: protein:decreased expression:plasma |
RGD |
PMID:18221301 PMID:21733090 PMID:25787238 PMID:26857650 PMID:27298104 PMID:27557564 More...
|
RGD:14696813 RGD:14696814 RGD:14696829 RGD:14696833 RGD:14696835 RGD:14696836 |
NCBI chrNW_004955425:7,704,371...7,708,951
Ensembl chrNW_004955425:7,702,137...7,709,006
|
|
G |
Mbtps1 |
membrane bound transcription factor peptidase, site 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14563831 |
|
NCBI chrNW_004955564:176,230...226,555
Ensembl chrNW_004955564:176,230...228,587
|
|
G |
Mbtps2 |
membrane bound transcription factor peptidase, site 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14563831 |
|
NCBI chrNW_004955509:2,185,054...2,222,497
Ensembl chrNW_004955509:2,184,522...2,222,505
|
|
G |
Mcm10 |
minichromosome maintenance 10 replication initiation factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955462:1,151,163...1,186,601
Ensembl chrNW_004955462:1,153,058...1,188,799
|
|
G |
Mcm2 |
minichromosome maintenance complex component 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955429:16,012,345...16,027,151
Ensembl chrNW_004955429:16,012,173...16,027,277
|
|
G |
Mcm7 |
minichromosome maintenance complex component 7 |
susceptibility |
ISO |
associated with hepatitis B;DNA:SNP:promoter: (rs999885) (human) associated with hepatitis B;miRNA:increased expression:liver (human) |
RGD |
PMID:24416400 PMID:27298561 |
RGD:15042853 RGD:15042885 |
NCBI chrNW_004955573:763,358...770,782
Ensembl chrNW_004955573:763,358...775,489
|
|
G |
Mcm9 |
minichromosome maintenance 9 homologous recombination repair factor |
|
ISO |
OMIM:114550 |
MouseDO |
|
|
NCBI chrNW_004955436:1,642,337...1,661,362
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
susceptibility |
ISO |
DNA:transversion:promoter:g.-309T>G (human) |
RGD |
PMID:20019189 |
RGD:2317357 |
NCBI chrNW_004955458:15,264,028...15,287,290
Ensembl chrNW_004955458:15,263,739...15,286,808
|
|
G |
Me1 |
malic enzyme 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21147110 |
|
NCBI chrNW_004955411:10,938,580...11,084,171
Ensembl chrNW_004955411:10,938,944...11,065,085
|
|
G |
Mecp2 |
methyl-CpG binding protein 2 |
|
ISO |
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:11844796 PMID:26189965 |
RGD:2289670 |
NCBI chrNW_004955580:674,014...737,586
Ensembl chrNW_004955580:679,109...735,288
|
|
G |
Med1 |
mediator complex subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20007298 |
|
NCBI chrNW_004955451:14,204,326...14,237,809
Ensembl chrNW_004955451:14,202,744...14,237,797
|
|
G |
Melk |
maternal embryonic leucine zipper kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955419:29,718,291...29,815,163
Ensembl chrNW_004955419:29,717,978...29,815,170
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
severity |
ISO |
protein:increased expression:liver (human) ClinVar Annotator: match by term: Hepatocellular cancer |
RGD OMIM ClinVar |
PMID:21774103 PMID:21970370 PMID:22703879 PMID:24728327 PMID:25741868 PMID:28259294 PMID:28492532 PMID:29303510 PMID:29641532 More...
|
RGD:152995524 |
NCBI chrNW_004955432:22,440,671...22,519,592
Ensembl chrNW_004955432:22,440,637...22,517,647
|
|
G |
Mfsd2a |
MFSD2 lysolipid transporter A, lysophospholipid |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955452:17,430,850...17,443,830
Ensembl chrNW_004955452:17,430,219...17,443,830
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955477:5,847,288...5,875,970
|
|
G |
Mlxipl |
MLX interacting protein like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21147110 |
|
NCBI chrNW_004955456:14,096,530...14,116,687
Ensembl chrNW_004955456:14,096,531...14,117,269
|
|
G |
Mme |
membrane metalloendopeptidase |
|
ISO |
|
RGD |
PMID:8302012 |
RGD:13801035 |
NCBI chrNW_004955448:6,193,113...6,311,666
Ensembl chrNW_004955448:6,226,059...6,314,949
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33010264 |
|
NCBI chrNW_004955409:37,438,924...37,448,704
Ensembl chrNW_004955409:37,440,541...37,448,437
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20084675 |
|
NCBI chrNW_004955433:13,024,844...13,050,041
Ensembl chrNW_004955433:13,024,418...13,052,775
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20084675 PMID:21681821 |
RGD:8547864 |
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
|
|
G |
Mpl |
MPL proto-oncogene, thrombopoietin receptor |
|
ISO |
human cells in mouse model |
RGD |
PMID:23157389 |
RGD:126925755 |
NCBI chrNW_004955537:2,922,156...2,937,223
Ensembl chrNW_004955537:2,922,156...2,937,223
|
|
G |
Mpo |
myeloperoxidase |
susceptibility disease_progression |
ISO |
associated with liver cirrhosis; DNA:SNP:promoter:-463G>A( rs2333227)(human) associated with liver cirrhosis with Hepatitis C;DNA:SNP:promoter:-463G>A(human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19731237 PMID:21907168 |
RGD:26923907 RGD:27095879 |
NCBI chrNW_004955451:4,743,744...4,753,358
Ensembl chrNW_004955451:4,743,744...4,753,358
|
|
G |
Mro |
maestro |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955402:35,745,823...35,765,507
Ensembl chrNW_004955402:35,745,692...35,765,887
|
|
G |
Msh3 |
mutS homolog 3 |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular cancer |
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004955418:29,149,595...29,274,067
Ensembl chrNW_004955418:29,150,085...29,274,437
|
|
G |
Msh5 |
mutS homolog 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955437:275,976...297,268
Ensembl chrNW_004955437:279,744...297,153
|
|
G |
Mtbp |
MDM2 binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29765550 |
|
NCBI chrNW_004955417:25,824,251...25,893,752
Ensembl chrNW_004955417:25,824,441...25,893,521
|
|
G |
Mtdh |
metadherin |
treatment |
ISO |
human cells in a mouse model |
RGD |
PMID:26351209 |
RGD:11096879 |
NCBI chrNW_004955417:13,479,398...13,540,706
Ensembl chrNW_004955417:13,479,762...13,537,950
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:3878730 |
RGD:2302305 |
NCBI chrNW_004955424:11,538,344...11,550,119
Ensembl chrNW_004955424:11,539,399...11,550,220
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
disease_progression susceptibility onset |
ISO |
DNA:SNP: :677C>T(human) DNA:SNP,haplotype: :677C>T, 1298A>C(human) DNA:SNP: :1298A>C(human) DNA:SNPs: :677C>T, 1298A>C(human) |
RGD |
PMID:17503006 PMID:17659576 PMID:19035314 PMID:23996892 |
RGD:14696703 RGD:14696704 RGD:14696707 RGD:14696708 |
NCBI chrNW_004955486:2,096,379...2,112,240
Ensembl chrNW_004955486:2,096,379...2,112,240
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
severity |
ISO |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver (human) |
CTD RGD |
PMID:21147110 PMID:25371154 |
RGD:152995471 |
NCBI chrNW_004955486:2,487,642...2,599,694
Ensembl chrNW_004955486:2,487,642...2,599,694
|
|
G |
Mtrr |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
susceptibility |
ISO |
DNA:SNP: :66A>G(human) |
RGD |
PMID:19035314 |
RGD:14696707 |
NCBI chrNW_004955504:5,412,290...5,435,409
Ensembl chrNW_004955504:5,413,586...5,435,645
|
|
G |
Mvk |
mevalonate kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21147110 |
|
NCBI chrNW_004955455:8,933,250...8,953,883
Ensembl chrNW_004955455:8,930,125...8,953,894
|
|
G |
Mybl2 |
MYB proto-oncogene like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955445:13,496,919...13,530,689
Ensembl chrNW_004955445:13,496,919...13,530,689
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
treatment severity |
ISO |
OMIM:114550 mRNA:increased expression:liver (human) mRNA:increased expression:liver (rat) CTD Direct Evidence: marker/mechanism |
RGD MouseDO CTD |
PMID:9029167 PMID:12029619 PMID:15565109 PMID:21644509 PMID:22076107 PMID:22129741 PMID:22434528 PMID:29698666 More...
|
RGD:6903288 RGD:7240567 RGD:7240695 RGD:7241004 |
NCBI chrNW_004955461:2,714,022...2,718,872
Ensembl chrNW_004955461:2,714,022...2,718,982
|
|
G |
Myd88 |
MYD88 innate immune signal transduction adaptor |
exacerbates treatment ameliorates |
ISO |
mRNA:increased expression:liver (human) human gene and cell in a mouse model mouse cell line in a mouse model protein:increased expression:liver (human) human cell line in a mouse model protein, mRNA:decreased expression:liver (human) |
RGD |
PMID:17615358 PMID:24603331 PMID:26985932 PMID:28370778 PMID:29022910 PMID:31068809 PMID:31074165 PMID:32144747 PMID:33575076 More...
|
RGD:150520022 RGD:150520169 RGD:150521532 RGD:150521534 RGD:150524327 RGD:150524329 RGD:150524330 RGD:150524334 RGD:150530285 |
NCBI chrNW_004955427:25,553,589...25,557,654
Ensembl chrNW_004955427:25,553,589...25,559,138
|
|
G |
Nbn |
nibrin |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular cancer |
ClinVar |
PMID:9590180 PMID:9590181 PMID:9620777 PMID:10398434 PMID:10799436 PMID:10848790 PMID:10852373 PMID:11093281 PMID:11279524 PMID:11953735 PMID:12123493 PMID:12505263 PMID:12833396 PMID:12845677 PMID:14973119 PMID:15185344 PMID:15279809 PMID:16033915 PMID:16544999 PMID:17103455 PMID:18606567 PMID:18940477 PMID:19635536 PMID:19908051 PMID:20444919 PMID:22131123 PMID:22293976 PMID:22373003 PMID:22491912 PMID:22941933 PMID:23317186 PMID:24033266 PMID:24113799 PMID:25485873 PMID:25741868 PMID:25980754 PMID:26083025 PMID:26467025 PMID:26822949 PMID:26845104 PMID:27150568 PMID:27616075 PMID:28492532 PMID:28873162 PMID:29368341 PMID:29419426 PMID:30426508 PMID:31173646 PMID:32295079 PMID:33050356 PMID:33471974 PMID:33471991 PMID:33840814 PMID:34072463 PMID:34072659 PMID:34544220 PMID:35309086 More...
|
|
NCBI chrNW_004955417:6,840,916...6,880,479
Ensembl chrNW_004955417:6,839,312...6,880,133
|
|
G |
Ncapg |
non-SMC condensin I complex subunit G |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955480:6,399,891...6,430,617
Ensembl chrNW_004955480:6,399,960...6,430,645
|
|
G |
Ncaph |
non-SMC condensin I complex subunit H |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955470:3,878,896...3,909,087
Ensembl chrNW_004955470:3,878,883...3,909,146
|
|
G |
Ncoa2 |
nuclear receptor coactivator 2 |
exacerbates |
ISO |
|
RGD |
PMID:22556267 PMID:28273073 |
RGD:153002573 RGD:153002576 |
NCBI chrNW_004955444:9,313,748...9,587,109
Ensembl chrNW_004955444:9,313,447...9,584,913
|
|
G |
Ndc80 |
NDC80 kinetochore complex component |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955402:7,692,009...7,728,876
Ensembl chrNW_004955402:7,691,937...7,729,690
|
|
G |
Neil3 |
nei like DNA glycosylase 3 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (human) |
CTD RGD |
PMID:28284560 PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004955403:30,549,779...30,591,757
Ensembl chrNW_004955403:30,549,740...30,591,821
|
|
G |
Nek2 |
NIMA related kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955406:5,553,661...5,563,648
Ensembl chrNW_004955406:5,553,819...5,566,361
|
|
G |
Nf2 |
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor |
disease_progression |
ISO |
protein:decreased expression:liver DNA, protein:SNP, increased expression:intron, liver |
RGD |
PMID:26443326 PMID:27289045 PMID:29130106 |
RGD:11076529 RGD:150530489 RGD:150530504 |
NCBI chrNW_004955455:3,862,804...3,950,669
Ensembl chrNW_004955455:3,862,347...3,951,891
|
|
G |
Nfe2l1 |
NFE2 like bZIP transcription factor 1 |
|
ISO |
OMIM:114550 |
MouseDO |
|
|
NCBI chrNW_004955451:13,088,680...13,099,839
Ensembl chrNW_004955451:13,088,906...13,099,839
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:22561517 PMID:31546024 |
RGD:21201310 |
NCBI chrNW_004955403:19,510,122...19,536,428
Ensembl chrNW_004955403:19,532,103...19,535,944
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
disease_progression treatment |
ISO |
associated with Chronic Hepatitis B;DNA:insertion/deletion:3'utr: -94ins/delATTG (rs28720239) (human) |
RGD |
PMID:19797428 PMID:25999787 |
RGD:152177911 RGD:40400751 |
NCBI chrNW_004955496:5,842,734...5,950,995
Ensembl chrNW_004955496:5,842,600...5,927,885
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
susceptibility disease_progression |
ISO |
CTD Direct Evidence: therapeutic associated with hepatitis B;DNA:SNP:promoter:-826C>T (rs2233406) (human) associated with Chronic Hepatitis B;DNA:SNPs,haplotype:3'utr,promoter: 826C>T,881A>G (rs2233406,rs3138053) (human) |
CTD RGD |
PMID:19797428 PMID:22022477 PMID:25223483 |
RGD:40400751 RGD:40902986 |
NCBI chrNW_004955409:25,691,673...25,695,151
Ensembl chrNW_004955409:25,691,534...25,697,520
|
|
G |
Nkx3-1 |
NK3 homeobox 1 |
treatment |
ISO |
mRNA:decreased expression:liver human gene in a mouse model |
RGD |
PMID:28972178 |
RGD:14401599 |
NCBI chrNW_004955403:46,807,846...46,809,924
Ensembl chrNW_004955403:46,806,178...46,836,310
|
|
G |
Nlrc3 |
NLR family CARD domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30081150 |
|
NCBI chrNW_004955442:13,795,322...13,834,362
Ensembl chrNW_004955442:13,814,434...13,833,222
|
|
G |
Nlrc5 |
NLR family CARD domain containing 5 |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:27338800 |
RGD:15003194 |
NCBI chrNW_004955433:14,670,273...14,752,739
Ensembl chrNW_004955433:14,670,207...14,751,782
|
|
G |
Nnmt |
nicotinamide N-methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955412:15,892,906...15,916,166
|
|
G |
Nos2 |
nitric oxide synthase 2 |
treatment |
ISO |
|
RGD |
PMID:25999787 |
RGD:152177911 |
NCBI chrNW_004955481:5,197,957...5,232,406
Ensembl chrNW_004955481:5,201,234...5,231,961
|
|
G |
Notch3 |
notch receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955495:8,012,370...8,048,616
Ensembl chrNW_004955495:8,012,502...8,047,710
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0 group B member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23811326 |
|
NCBI chrNW_004955452:6,251,047...6,253,541
Ensembl chrNW_004955452:6,250,889...6,254,541
|
|
G |
Nr1h2 |
nuclear receptor subfamily 1 group H member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21147110 |
|
NCBI chrNW_004955559:731,630...736,973
Ensembl chrNW_004955559:730,670...737,505
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1 group H member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism OMIM:114550 mRNA:splice variant(s):liver (human) intestinally expressed human gene in mouse model |
CTD MouseDO RGD |
PMID:23213087 PMID:23811326 PMID:24954587 PMID:25496033 |
RGD:14696796 RGD:14928330 RGD:14928334 |
NCBI chrNW_004955405:36,160,360...36,236,258
Ensembl chrNW_004955405:36,160,049...36,237,751
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
severity disease_progression |
ISO |
mRNA, protein:increased expression:liver (mouse, human) human gene in mouse model |
RGD |
PMID:21993994 PMID:30685691 |
RGD:14696775 RGD:14696793 |
NCBI chrNW_004955435:18,001,517...18,009,105
Ensembl chrNW_004955435:18,001,517...18,009,103
|
|
G |
Nrg1 |
neuregulin 1 |
disease_progression |
ISO |
mRNA:increased expression:liver (human) associated with hepatitis C;mRNA:altered expression:liver (human |
RGD |
PMID:17393520 PMID:27514687 |
RGD:39456104 RGD:39456110 |
NCBI chrNW_004955463:8,009,436...9,037,116
Ensembl chrNW_004955463:8,009,530...9,037,116
|
|
G |
Nrp1 |
neuropilin 1 |
disease_progression |
ISO |
protein:decreased expression:liver |
RGD |
PMID:25333267 |
RGD:126848812 |
NCBI chrNW_004955462:4,101,997...4,241,012
Ensembl chrNW_004955462:4,101,999...4,241,012
|
|
G |
Nuf2 |
NUF2 component of NDC80 kinetochore complex |
disease_progression treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:28284560 PMID:30653265 PMID:31933938 |
RGD:28867240 RGD:28912742 |
NCBI chrNW_004955462:13,082,874...13,142,709
Ensembl chrNW_004955462:13,082,047...13,142,944
|
|
G |
Nusap1 |
nucleolar and spindle associated protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955416:8,178,493...8,208,336
Ensembl chrNW_004955416:8,178,826...8,207,747
|
|
G |
Oit3 |
oncoprotein induced transcript 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955437:18,721,556...18,745,369
Ensembl chrNW_004955437:18,718,242...18,745,434
|
|
G |
Olfml2a |
olfactomedin like 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955419:3,397,543...3,420,118
Ensembl chrNW_004955419:3,393,024...3,414,359
|
|
G |
Olfml2b |
olfactomedin like 2B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955462:14,299,919...14,336,576
Ensembl chrNW_004955462:14,299,596...14,337,662
|
|
G |
Orc1 |
origin recognition complex subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955464:6,761,046...6,787,144
Ensembl chrNW_004955464:6,764,992...6,787,066
|
|
G |
Otc |
ornithine transcarbamylase |
severity |
ISO |
mRNA:altered expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004955601:481,524...543,176
Ensembl chrNW_004955601:481,480...543,176
|
|
G |
Pafah1b1 |
platelet activating factor acetylhydrolase 1b regulatory subunit 1 |
disease_progression |
ISO |
mRNA,protein:decreased expression:liver: |
RGD |
PMID:21569763 |
RGD:12790589 |
NCBI chrNW_004955481:608,897...686,454
Ensembl chrNW_004955481:608,897...686,452
|
|
G |
Pamr1 |
peptidase domain containing associated with muscle regeneration 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955422:10,734,673...10,913,258
Ensembl chrNW_004955422:10,828,428...10,913,309
|
|
G |
Park7 |
Parkinsonism associated deglycase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955486:4,974,130...4,985,927
Ensembl chrNW_004955486:4,969,497...4,985,885
|
|
G |
Parp1 |
poly(ADP-ribose) polymerase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18695907 |
|
NCBI chrNW_004955489:520,875...557,609
Ensembl chrNW_004955489:520,875...557,615
|
|
G |
Pbk |
PDZ binding kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955403:50,332,167...50,353,147
Ensembl chrNW_004955403:50,330,981...50,352,570
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 PMID:28284560 |
|
NCBI chrNW_004955445:1,909,012...1,914,032
Ensembl chrNW_004955445:1,908,946...1,915,002
|
|
G |
Pclaf |
PCNA clamp associated factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955450:11,072,778...11,082,687
Ensembl chrNW_004955450:11,072,786...11,082,687
|
|
G |
Pcna |
proliferating cell nuclear antigen |
treatment |
ISO |
protein:increased expression:liver: |
RGD |
PMID:23219601 PMID:25999787 |
RGD:10448993 RGD:152177911 |
NCBI chrNW_004955415:15,744,601...15,748,910
Ensembl chrNW_004955415:15,744,601...15,749,673
|
|
G |
Pdcd1 |
programmed cell death 1 |
disease_progression |
ISO |
associated with hepatitis B;DNA:SNP: : +8669 A>G (human) |
RGD |
PMID:21912640 PMID:27034168 |
RGD:40818257 RGD:41410800 |
NCBI chrNW_004955542:49,290...57,747
Ensembl chrNW_004955542:49,259...58,823
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20506153 |
|
NCBI chrNW_004955413:25,150,702...25,166,987
Ensembl chrNW_004955413:25,148,062...25,166,987
|
|
G |
Pdgfrl |
platelet derived growth factor receptor like |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma |
OMIM ClinVar |
PMID:7898930 |
|
NCBI chrNW_004955552:2,041,267...2,077,971
Ensembl chrNW_004955552:2,041,267...2,077,972
|
|
G |
Pdia3 |
protein disulfide isomerase family A member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955416:10,197,957...10,221,104
Ensembl chrNW_004955416:10,198,099...10,220,792
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28003426 |
|
NCBI chrNW_004955432:12,169,548...12,182,064
Ensembl chrNW_004955432:12,169,435...12,182,409
|
|
G |
Pfas |
phosphoribosylformylglycinamidine synthase |
|
ISO |
protein:increased activity:hepatoma (rat) protein:increased expression:liver |
RGD |
PMID:6722784 |
RGD:5135276 |
NCBI chrNW_004955467:8,640,044...8,660,950
Ensembl chrNW_004955467:8,640,044...8,660,979
|
|
G |
Pfn2 |
profilin 2 |
disease_progression |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004955448:1,199,447...1,201,718
Ensembl chrNW_004955448:1,199,688...1,203,400
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 |
|
NCBI chrNW_004955486:3,344,705...3,356,906
Ensembl chrNW_004955486:3,343,863...3,357,066
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955557:1,566,534...1,584,799
|
|
G |
Phb1 |
prohibitin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955451:12,110,290...12,119,870
Ensembl chrNW_004955451:12,110,290...12,120,124
|
|
G |
Phf6 |
PHD finger protein 6 |
exacerbates |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:30888215 PMID:31329335 |
RGD:155260288 RGD:155260308 |
NCBI chrNW_004955473:527,005...586,589
Ensembl chrNW_004955473:527,005...586,627
|
|
G |
Phlda1 |
pleckstrin homology like domain family A member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955405:15,318,785...15,321,316
Ensembl chrNW_004955405:15,320,005...15,321,301
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
treatment no_association severity susceptibility |
ISO |
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma DNA:mutation:exon: DNA:mutations:exons: DNA:SNPs: :rs17849071,rs17849079(human) |
OMIM ClinVar RGD |
PMID:15016963 PMID:15520168 PMID:15608678 PMID:16331247 PMID:17376864 PMID:17673550 PMID:20593314 PMID:22370636 PMID:22658544 PMID:22729222 PMID:22729224 PMID:23066039 PMID:23100325 PMID:23946963 PMID:24033266 PMID:24673525 PMID:24782230 PMID:25741868 PMID:25999787 PMID:26266975 PMID:26266985 PMID:26627007 PMID:26822237 PMID:26823876 PMID:27126994 PMID:27626068 PMID:27631024 PMID:28492532 PMID:29988677 PMID:31536475 PMID:31775759 PMID:34008892 PMID:34496175 PMID:37712948 More...
|
RGD:11556371 RGD:14402404 RGD:14402405 RGD:152177911 |
NCBI chrNW_004955420:8,355,415...8,427,024
Ensembl chrNW_004955420:8,356,353...8,427,024
|
|
G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
treatment |
ISO |
|
RGD |
PMID:25999787 |
RGD:152177911 |
NCBI chrNW_004955501:251,829...381,255
Ensembl chrNW_004955501:259,645...379,909
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
treatment |
ISO |
|
RGD |
PMID:25999787 PMID:31801250 |
RGD:151893509 RGD:152177911 |
NCBI chrNW_004955446:1,020,707...1,098,327
Ensembl chrNW_004955446:1,020,043...1,098,820
|
|
G |
Pik3r2 |
phosphoinositide-3-kinase regulatory subunit 2 |
treatment |
ISO |
|
RGD |
PMID:25999787 |
RGD:152177911 |
NCBI chrNW_004955524:3,234,111...3,241,445
Ensembl chrNW_004955524:3,234,111...3,241,173
|
|
G |
Pinx1 |
PIN2 (TERF1) interacting telomerase inhibitor 1 |
disease_progression |
ISO |
associated with Chronic Hepatitis B; DNA:SNP::rs1469557(human) |
RGD |
PMID:27221889 |
RGD:152977752 |
NCBI chrNW_004955403:52,284,378...52,361,924
Ensembl chrNW_004955403:52,284,166...52,362,206
|
|
G |
Pitpnm3 |
PITPNM family member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955467:11,973,181...12,051,388
Ensembl chrNW_004955467:11,973,181...12,051,593
|
|
G |
Pitx1 |
paired like homeodomain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955408:30,197,374...30,202,887
Ensembl chrNW_004955408:30,197,061...30,203,054
|
|
G |
Pkm |
pyruvate kinase M1/2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19363144 |
|
NCBI chrNW_004955450:4,907,962...4,935,179
Ensembl chrNW_004955450:4,907,788...4,936,199
|
|
G |
Pkmyt1 |
protein kinase, membrane associated tyrosine/threonine 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955442:14,368,110...14,372,365
Ensembl chrNW_004955442:14,364,031...14,372,365
|
|
G |
Pkp1 |
plakophilin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955406:37,420,019...37,465,588
Ensembl chrNW_004955406:37,419,856...37,465,655
|
|
G |
Plac8 |
placenta associated 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955474:6,518,459...6,533,251
Ensembl chrNW_004955474:6,522,204...6,534,312
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
OMIM:114550 |
MouseDO |
|
|
NCBI chrNW_004955437:17,995,726...18,000,542
Ensembl chrNW_004955437:17,994,537...18,000,209
|
|
G |
Plcg1 |
phospholipase C gamma 1 |
ameliorates |
ISO |
human cell line in a mouse model |
RGD |
PMID:30623526 |
RGD:151356937 |
NCBI chrNW_004955445:15,787,496...15,823,859
Ensembl chrNW_004955445:15,787,496...15,823,859
|
|
G |
Plk1 |
polo like kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955493:2,206,353...2,217,231
Ensembl chrNW_004955493:2,206,353...2,217,231
|
|
G |
Plk4 |
polo like kinase 4 |
sexual_dimorphism |
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:21324136 |
RGD:27226690 |
NCBI chrNW_004955428:13,548,485...13,566,786
Ensembl chrNW_004955428:13,549,000...13,566,516
|
|
G |
Plod3 |
procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 |
treatment |
ISO |
mRNA, protein:increased expression:liver (human) |
RGD |
PMID:29059470 |
RGD:155791679 |
NCBI chrNW_004955456:16,082,424...16,090,773
Ensembl chrNW_004955456:16,082,437...16,093,389
|
|
G |
Plvap |
plasmalemma vesicle associated protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955524:885,245...895,552
Ensembl chrNW_004955524:885,276...893,044
|
|
G |
Plxdc1 |
plexin domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955451:13,982,443...14,028,235
Ensembl chrNW_004955451:13,982,443...14,028,235
|
|
G |
Pml |
PML nuclear body scaffold |
disease_progression exacerbates ameliorates |
ISO |
protein:increased expression:liver (human) associated with hepatitis C mRNA:increased expression:liver (mouse) |
RGD |
PMID:11511788 PMID:26118777 PMID:31144474 |
RGD:41404685 RGD:41404687 RGD:41404690 |
NCBI chrNW_004955450:3,654,854...3,692,057
Ensembl chrNW_004955450:3,656,498...3,692,406
|
|
G |
Pms2 |
PMS1 homolog 2, mismatch repair system component |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma |
ClinVar |
|
|
NCBI chrNW_004955460:13,762,854...13,791,462
|
|
G |
Pnpla3 |
patatin like phospholipase domain containing 3 |
|
ISO |
associated with Hepatitis C, Chronic;DNA:SNP: :rs738409 (p.I148M) (human) |
RGD |
PMID:21319195 |
RGD:14981585 |
NCBI chrNW_004955413:28,879,646...28,896,224
Ensembl chrNW_004955413:28,879,748...28,893,938
|
|
G |
Pnpt1 |
polyribonucleotide nucleotidyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955424:27,407,451...27,449,830
Ensembl chrNW_004955424:27,407,489...27,448,992
|
|
G |
Polg |
DNA polymerase gamma, catalytic subunit |
susceptibility |
ISO |
DNA:SNPs:introns: (rs1061316, rs758130) (human) |
RGD |
PMID:28457473 |
RGD:15039387 |
NCBI chrNW_004955416:15,773,005...15,788,736
Ensembl chrNW_004955416:15,773,473...15,788,651
|
|
G |
Pon1 |
paraoxonase 1 |
disease_progression |
ISO |
mRNA:decreased expression:liver (human) |
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004955432:11,893,473...11,923,035
Ensembl chrNW_004955432:11,893,473...11,923,339
|
|
G |
Pot1 |
protection of telomeres 1 |
disease_progression |
ISO |
associated with hepatitis B;DNA:SNP: :rs7784168(human) |
RGD |
PMID:23907815 |
RGD:152975963 |
NCBI chrNW_004955479:6,140,599...6,230,512
Ensembl chrNW_004955479:6,140,501...6,209,031
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
susceptibility |
ISO |
associated with hepatitis B;DNA:missense mutation:cds:p.L162V (human) |
RGD |
PMID:19119483 |
RGD:15042881 |
NCBI chrNW_004955413:30,306,563...30,366,245
Ensembl chrNW_004955413:30,307,219...30,359,500
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
severity |
ISO |
protein:decreased expression:liver CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:16374840 PMID:27451128 |
RGD:14694822 |
NCBI chrNW_004955429:14,814,690...14,936,869
Ensembl chrNW_004955429:14,873,908...14,937,387
|
|
G |
Ppat |
phosphoribosyl pyrophosphate amidotransferase |
|
ISO |
protein:increased activity:hepatoma (rat) |
RGD |
PMID:6327016 |
RGD:5135035 |
NCBI chrNW_004955447:14,552,846...14,607,416
Ensembl chrNW_004955447:14,574,407...14,607,416
|
|
G |
Ppp1r1a |
protein phosphatase 1 regulatory inhibitor subunit 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15010824 |
|
NCBI chrNW_004955458:1,819,366...1,823,864
Ensembl chrNW_004955458:1,819,366...1,823,867
|
|
G |
Ppp1r9a |
protein phosphatase 1 regulatory subunit 9A |
onset |
ISO |
protein:increased expression:liver (rat) |
RGD |
PMID:20935162 |
RGD:10002734 |
NCBI chrNW_004955432:11,607,269...11,891,568
Ensembl chrNW_004955432:11,608,382...11,886,044
|
|
G |
Ppp1r9b |
protein phosphatase 1 regulatory subunit 9B |
severity |
ISO |
mRNA, protein:decreased expression:liver (human) |
RGD |
PMID:23591196 |
RGD:10043803 |
NCBI chrNW_004955451:11,516,548...11,530,263
Ensembl chrNW_004955451:11,516,548...11,530,830
|
|
G |
Prc1 |
protein regulator of cytokinesis 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955416:15,023,620...15,045,958
Ensembl chrNW_004955416:15,023,620...15,045,958
|
|
G |
Prdm1 |
PR/SET domain 1 |
disease_progression |
ISO |
associated with hepatitis B; associated with hepatitis B;DNA:SNP: :rs1010273(human) |
RGD |
PMID:31100710 PMID:31376415 |
RGD:150530465 RGD:150530466 |
NCBI chrNW_004955411:31,434,503...31,455,995
Ensembl chrNW_004955411:31,434,503...31,456,056
|
|
G |
Prdx1 |
peroxiredoxin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27517622 |
|
NCBI chrNW_004955464:12,761,390...12,773,413
Ensembl chrNW_004955464:12,761,401...12,773,146
|
|
G |
Prdx2 |
peroxiredoxin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955415:31,880,801...31,884,453
Ensembl chrNW_004955415:31,880,588...31,884,778
|
|
G |
Prdx6 |
peroxiredoxin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472284 |
|
NCBI chrNW_004955406:13,717,267...13,728,216
Ensembl chrNW_004955406:13,717,267...13,728,216
|
|
G |
Prex2 |
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2 |
exacerbates |
ISO |
protein:increased expression:liver (human) mRNA:increased expression:liver (human) mRNA:decreased expression:liver (human) |
RGD |
PMID:25151370 PMID:28000796 PMID:28205209 PMID:31776854 |
RGD:151665185 RGD:151665186 RGD:151665188 RGD:151665343 |
NCBI chrNW_004955444:11,154,318...11,414,680
Ensembl chrNW_004955444:11,154,318...11,414,075
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
severity |
ISO |
protein:decreased expression:liver (human) |
RGD |
PMID:28862485 |
RGD:13432206 |
NCBI chrNW_004955439:18,664,230...19,953,358
Ensembl chrNW_004955439:18,664,379...19,951,152
|
|
G |
Prl |
prolactin |
onset |
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:22392353 |
RGD:125097525 |
NCBI chrNW_004955483:4,495,257...4,503,377
|
|
G |
Prom1 |
prominin 1 |
|
ISO |
mRNA:increased expression:liver (mouse) |
RGD |
PMID:26569409 |
RGD:11344640 |
NCBI chrNW_004955480:7,955,501...8,059,537
Ensembl chrNW_004955480:7,961,389...8,059,589
|
|
G |
Ptch1 |
patched 1 |
disease_progression severity |
ISO |
|
RGD |
PMID:18538319 PMID:22911366 |
RGD:150523837 RGD:150523842 |
NCBI chrNW_004955422:22,362,330...22,418,062
Ensembl chrNW_004955422:22,362,221...22,427,622
|
|
G |
Pten |
phosphatase and tensin homolog |
severity treatment exacerbates |
ISO |
CTD Direct Evidence: marker/mechanism OMIM:114550 protein:decreased expression:liver (human) associated with hepatitis B;protein:decreased expression:liver (human) associated with hepatitis C, liver cirrhosis;protein:decreased expression:liver (human) |
CTD MouseDO RGD |
PMID:12115563 PMID:12673720 PMID:27022031 PMID:29303510 PMID:30690477 PMID:31801250 More...
|
RGD:127285591 RGD:127285603 RGD:127285610 RGD:151893509 RGD:152995524 |
NCBI chrNW_004955425:5,007,811...5,091,829
Ensembl chrNW_004955425:5,014,147...5,091,829
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
susceptibility treatment severity |
ISO |
DNA:SNP:promoter:-1195A>G (rs689466) (human) CTD Direct Evidence: marker/mechanism mRNA,protein:decreased expression:liver protein:increased expression:liver, cytosol |
RGD CTD |
PMID:11872629 PMID:12024111 PMID:14563831 PMID:15800977 PMID:16374840 PMID:17510421 PMID:18373278 PMID:24720952 PMID:24759835 PMID:25999787 More...
|
RGD:14695010 RGD:14695011 RGD:14695012 RGD:152177911 RGD:2300283 |
NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171
|
|
G |
Pth1r |
parathyroid hormone 1 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955420:25,274,269...25,291,984
Ensembl chrNW_004955420:25,273,431...25,296,471
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:14578863 PMID:17203219 |
RGD:2292584 |
NCBI chrNW_004955461:14,337,914...14,622,779
Ensembl chrNW_004955461:14,337,914...14,556,931
|
|
G |
Ptpn13 |
protein tyrosine phosphatase non-receptor type 13 |
susceptibility disease_progression |
ISO |
DNA:SNP: :p.Y2081D(human) |
RGD |
PMID:16489062 PMID:26801674 |
RGD:152176666 RGD:152599190 |
NCBI chrNW_004955474:2,988,109...3,140,520
Ensembl chrNW_004955474:2,988,639...3,140,513
|
|
G |
Ptprb |
protein tyrosine phosphatase receptor type B |
disease_progression |
ISO |
mRNA:decreased expression:liver (human) |
RGD |
PMID:30237408 |
RGD:151361293 |
NCBI chrNW_004955405:10,647,777...10,766,909
Ensembl chrNW_004955405:10,648,818...10,766,993
|
|
G |
Pttg1 |
PTTG1 regulator of sister chromatid separation, securin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955408:14,293,704...14,301,357
|
|
G |
Pygl |
glycogen phosphorylase L |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:2885971 |
|
NCBI chrNW_004955409:11,970,112...12,007,102
Ensembl chrNW_004955409:11,970,112...12,007,102
|
|
G |
Rac1 |
Rac family small GTPase 1 |
exacerbates |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human) mRNA:increased expression:liver (human) |
CTD RGD |
PMID:18506888 PMID:20522449 PMID:33482578 |
RGD:153298967 RGD:153350129 |
NCBI chrNW_004955460:13,270,159...13,295,562
Ensembl chrNW_004955460:13,270,159...13,311,351
|
|
G |
Racgap1 |
Rac GTPase activating protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955547:584,885...615,883
Ensembl chrNW_004955547:581,134...616,087
|
|
G |
Rad21 |
RAD21 cohesin complex component |
treatment exacerbates susceptibility |
ISO |
human cells in a mouse model mRNA:increased expression:liver (human) associated with hepatitis c, liver cirrhosis;mRNA:increased expression:liver (human) protein:increased expression:liver (human) |
RGD |
PMID:28434945 PMID:30698808 PMID:32596342 PMID:33251678 |
RGD:150520026 RGD:150520029 RGD:150520030 RGD:150520035 |
NCBI chrNW_004955417:22,941,549...22,966,395
Ensembl chrNW_004955417:22,941,479...22,966,837
|
|
G |
Rad50 |
RAD50 double strand break repair protein |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma |
ClinVar |
PMID:16385572 PMID:18281469 PMID:19409520 PMID:24894818 PMID:25452441 PMID:25741868 PMID:26467025 PMID:28492532 PMID:29961768 PMID:31159747 PMID:31589614 PMID:32295079 More...
|
|
NCBI chrNW_004955408:3,953,801...4,035,494
Ensembl chrNW_004955408:3,953,800...4,035,494
|
|
G |
Rad52 |
RAD52 homolog, DNA repair protein |
onset susceptibility |
ISO |
mRNA,protein:increased expression:liver (human) associated with hepatitis B;DNA:SNP:3'utr: (rs7963551) (human) |
RGD |
PMID:24729511 PMID:31719794 |
RGD:151361199 RGD:151361207 |
NCBI chrNW_004955454:6,206,195...6,227,859
Ensembl chrNW_004955454:6,215,129...6,231,726
|
|
G |
Rad54l |
RAD54 like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955464:11,996,512...12,033,525
Ensembl chrNW_004955464:11,996,512...12,033,490
|
|
G |
Rara |
retinoic acid receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18026104 |
|
NCBI chrNW_004955451:14,876,663...14,917,134
Ensembl chrNW_004955451:14,897,726...14,917,134
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:12029619 PMID:14961299 PMID:33841550 |
RGD:152998960 |
NCBI chrNW_004955431:1,960,765...2,124,576
Ensembl chrNW_004955431:1,960,661...2,124,576
|
|
G |
Rbm10 |
RNA binding motif protein 10 |
disease_progression |
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:32572914 |
RGD:151356975 |
NCBI chrNW_004955516:904,852...934,313
Ensembl chrNW_004955516:904,062...934,313
|
|
G |
Rcan1 |
regulator of calcineurin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955407:33,873,427...33,951,762
Ensembl chrNW_004955407:33,873,383...33,951,498
|
|
G |
Recql |
RecQ like helicase |
disease_progression |
ISO |
protein:increased expression:liver |
RGD |
PMID:18422747 |
RGD:2317370 |
NCBI chrNW_004955413:17,115,443...17,148,708
Ensembl chrNW_004955413:17,113,408...17,148,708
|
|
G |
Ret |
ret proto-oncogene |
severity |
ISO |
protein:increased expression:liver (human) ClinVar Annotator: match by term: Hepatocellular carcinoma |
RGD ClinVar |
PMID:7784092 PMID:7845675 PMID:7911697 PMID:9111992 PMID:9242375 PMID:9263528 PMID:11230481 PMID:12116277 PMID:14715928 PMID:15184865 PMID:15855933 PMID:16736292 PMID:17047083 PMID:17097365 PMID:18062802 PMID:25810047 PMID:26046350 PMID:28350084 PMID:28492532 PMID:29656518 More...
|
RGD:150340602 |
NCBI chrNW_004955546:1,221,995...1,252,147
Ensembl chrNW_004955546:1,221,995...1,253,946
|
|
G |
Rgn |
regucalcin |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:21683810 |
RGD:5509919 |
NCBI chrNW_004955516:958,416...978,829
Ensembl chrNW_004955516:955,680...978,910
|
|
G |
Rictor |
RPTOR independent companion of MTOR complex 2 |
severity |
ISO |
mRNA, protein:increased expression:liver (human) |
RGD |
PMID:25371154 PMID:29303510 |
RGD:152995471 RGD:152995524 |
NCBI chrNW_004955426:23,468,112...23,582,587
Ensembl chrNW_004955426:23,468,112...23,582,587
|
|
G |
Rit1 |
Ras like without CAAX 1 |
ameliorates |
ISO |
human cells in mouse model |
RGD |
PMID:31247273 |
RGD:152999016 |
NCBI chrNW_004955545:2,089,530...2,099,404
Ensembl chrNW_004955545:2,089,536...2,099,404
|
|
G |
Rnd3 |
Rho family GTPase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955440:16,106,555...16,113,337
|
|
G |
Rnf157 |
ring finger protein 157 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955506:6,043,473...6,125,157
Ensembl chrNW_004955506:6,043,784...6,123,613
|
|
G |
Rnf43 |
ring finger protein 43 |
exacerbates |
ISO |
human cells in a mouse model |
RGD |
PMID:23136185 |
RGD:151361219 |
NCBI chrNW_004955451:4,604,985...4,680,762
Ensembl chrNW_004955451:4,604,985...4,680,762
|
|
G |
Rnf6 |
ring finger protein 6 |
disease_progression |
ISO |
|
RGD |
PMID:30496760 |
RGD:151665757 |
NCBI chrNW_004955497:5,744,485...5,754,728
Ensembl chrNW_004955497:5,744,157...5,754,728
|
|
G |
Robo1 |
roundabout guidance receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955407:12,593,911...13,485,723
Ensembl chrNW_004955407:13,107,235...13,487,053
|
|
G |
Rps6 |
ribosomal protein S6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21147110 |
|
NCBI chrNW_004955434:21,744,045...21,745,646
Ensembl chrNW_004955434:21,744,082...21,746,626
|
|
G |
Rps6ka3 |
ribosomal protein S6 kinase A3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561517 |
|
NCBI chrNW_004955509:600,415...701,833
Ensembl chrNW_004955509:600,284...701,837
|
|
G |
Rrm1 |
ribonucleotide reductase catalytic subunit M1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18230555 |
|
NCBI chrNW_004955414:19,850,523...19,904,879
Ensembl chrNW_004955414:19,850,530...19,905,266
|
|
G |
Rrm2 |
ribonucleotide reductase regulatory subunit M2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18230555 PMID:28284560 |
|
NCBI chrNW_004955487:5,477,097...5,481,422
Ensembl chrNW_004955487:5,476,954...5,483,049
|
|
G |
Rspo3 |
R-spondin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28284560 |
|
NCBI chrNW_004955436:8,151,122...8,235,183
Ensembl chrNW_004955436:8,151,122...8,237,861
|
|
G |
Rtkn |
rhotekin |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:27922690 |
RGD:19165144 |
NCBI chrNW_004955424:11,344,504...11,358,344
Ensembl chrNW_004955424:11,344,220...11,360,832
|
|
G |
Rtp3 |
receptor transporter protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17693185 |
|
NCBI chrNW_004955420:25,545,752...25,550,044
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:liver |
CTD RGD |
PMID:17094378 PMID:28458013 |
RGD:126775147 |
NCBI chrNW_004955452:4,580,444...4,606,820
Ensembl chrNW_004955452:4,579,331...4,636,884
|
|
G |
Ryr3 |
ryanodine receptor 3 |
disease_progression |
ISO |
DNA:SNP:3'UTR:rs1044129(human) |
RGD |
PMID:26309413 |
RGD:155882454 |
NCBI chrNW_004955416:712,506...1,260,111
Ensembl chrNW_004955416:713,373...1,259,885
|
|
G |
S100a9 |
S100 calcium binding protein A9 |
disease_progression |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004955592:90,647...93,842
|
|
G |
Sardh |
sarcosine dehydrogenase |
severity |
ISO |
mRNA:altered expression:liver tumor (human) |
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004955513:2,933,918...2,975,645
Ensembl chrNW_004955513:2,933,918...2,976,931
|
|
G |
Sav1 |
salvador family WW domain containing protein 1 |
|
ISO |
OMIM:114550 |
MouseDO |
|
|
NCBI chrNW_004955409:12,200,721...12,221,520
Ensembl chrNW_004955409:12,200,721...12,220,410
|
|
G |
Scap |
SREBF chaperone |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14563831 |
|
NCBI chrNW_004955420:24,813,683...24,869,602
Ensembl chrNW_004955420:24,813,534...24,869,480
|
|
G |
Serpinb5 |
serpin family B member 5 |
disease_progression |
ISO |
associated with hepatitis B; |
RGD |
PMID:26296971 |
RGD:11520929 |
NCBI chrNW_004955402:47,248,665...47,276,017
Ensembl chrNW_004955402:47,248,932...47,276,834
|
|
G |
Serpinf1 |
serpin family F member 1 |
|
ISO |
associated with Human Viral Hepatitis, liver cirrhosis;protein:increased expression:serum (human) |
RGD |
PMID:27748324 |
RGD:27226704 |
NCBI chrNW_004955481:1,414,930...1,426,436
Ensembl chrNW_004955481:1,414,930...1,426,241
|
|
G |
Set |
SET nuclear proto-oncogene |
|
ISO |
ClinVar Annotator: match by term: Hepatocellular carcinoma |
ClinVar |
PMID:26822237 |
|
NCBI chrNW_004955570:1,104,447...1,117,682
|
|
G |
Sf3b1 |
splicing factor 3b subunit 1 |
treatment disease_progression |
ISO |
protein:increased expression:liver mRNA, protein:increased expression:liver |
RGD |
PMID:29954402 PMID:33038489 |
RGD:126790493 RGD:126790494 |
NCBI chrNW_004955403:3,134,960...3,163,395
Ensembl chrNW_004955403:3,134,955...3,166,121
|
|
G |
Sf3b4 |
splicing factor 3b subunit 4 |
treatment severity |
ISO |
mRNA, protein:increased expression:liver(human) human cells in mouse model mRNA, protein:increased expression:liver (human) mRNA, protein:increased expression:liver (rat) |
RGD |
PMID:29059470 PMID:30391496 |
RGD:155791679 RGD:155804298 |
NCBI chrNW_004955413:826,190...830,502
Ensembl chrNW_004955413:826,190...832,496
|
|